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The new generation left ventricular assist devices (LVADs) for treating end-stage heart 
failure are based upon turbodynamic (rotary) pumps. These devices have demonstrated several 
advantages over the previous pulsatile generation of LVADs, however they have also proven 
more difficult to control. Limited availability of observable hemodynamic variables and 
dynamically changing circulatory parameters impose particular difficulties for the LVAD 
controller to accommodate the blood flow demands of an active patient. The heart rate (HR) and 
systemic vascular resistance (SVR) are two important indicators of blood flow requirement of 
the body; but these variables have not been previously well exploited for LVAD control. In this 
dissertation, we will exploit these two variables and develop a control algorithm, based upon 
mathematical models of the cardiovascular system: both healthy and diseased, with built in 
autoregulatory control (baroreflex). The controller will respond to change in physiological state 
by adjusting the pump flow based on changes in HR and SVR as dictated by the baroreflex. 
Specific emphasis will be placed on hemodynamic changes during exercise in which the blood 
flow requirement increases dramatically to satisfy the increased oxygen consumption. As the 
first step in the development of the algorithm, we developed a model which will include the 
autoregulation of the cardiovascular system and the hydraulic power input from the pump. This 
model provided a more realistic simulation of the interaction between the LVAD and the 
cardiovascular system regulated by the baroreflex. Then the control algorithm was developed, 
implemented, and tested on the combined system of the LVAD and the cardiovascular system 
including the baroreflex. The performance of the proposed control algorithm is examined by 
comparing it to other control methods in response to varying levels of exercise and adding noises 
to the hemodynamic variables. The simulation results demonstrate that the controller is able to 
generate more blood flow through the pump than the constant speed and constant pump head 
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method, and the heart rate related pump speed method. The simulations with noise show that the 
controller is fairly robust to the measurement and estimate noises.
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1.0  INTRODUCTION 
Congestive heart failure is estimated to affect five million people in the US [1], which is 
characterized by impaired ventricular performance, exercise intolerance, and shortened life 
expectancy. Although drug therapy has had significant impact on quality of life and survival for 
moderate heart failure, mortality remains unacceptably high. Heart transplantation is the only 
accepted method to treat severe cases of the disease. Unfortunately, heart transplantation is 
limited by the number of donor organs, less than 3000 per year. The left ventricular assist device 
(LVAD) is therefore an alternative for many cases of end-stage heart failure [2, 3].  
The first generation of LVADs was based on positive displacement (pulsatile) pumps. 
Recently, turbodynamic pump have received growing acceptance on account of small size and 
high efficiency [4-8]. The rotary part of this type of pump, which is driven by a motor, generates 
a pressure difference across the pump in resistance of the arterial pressure. In a typical bypass 
application, where the inlet and outlet of the pump connect the apex of the left ventricle and the 
aorta respectively, the pump helps unload the failing left ventricle by reducing its work 
requirement and assuming the role of providing pressure and flow to the systemic circulation. 
However, the control of the LVAD emerges as a challenge for the rotary pump application. 
Because the pump actively draws blood from the left ventricle, the flow should be adjusted 
according to the available blood returning to the left ventricle.  
For a normal heart, the cardiac output (CO) is determined by two factors: stroke volume 
(SV) and heart rate (HR), 
CO SV HR= ∗       
Larger stroke volume and higher heart rate imply larger CO. Stroke volume increase is the result 
of a complex physiological process: increasing preload, increasing contractility and decreasing 
afterload. Preload is the amount of the venous blood returning to the heart. The contractility of 
the heart is an index of its strength of contraction. The afterload refers to the systemic vascular 
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resistance (SVR), the output load of the left ventricle. More generally, the physiological status of 
the patient may demonstrate a wide range of variation, due to exercise intensity and emotional 
changes. For a patient with heart failure, one or more of these functions may be damaged or 
attenuated therefore heart transplantation or the augment of the LVAD is needed. As learned 
with total artificial hearts, the inability of the device to respond to the blood flow demand of the 
body can dramatically impact the quality of life for these patients [9]. Thus a controller that can 
detect and adapt to the real time physiological changes of the body is crucial for the LVAD 
recipients leaving hospital, returning to normal lifestyle and improving the quality of life.  
Furthermore, two detrimental situations, backflow and suction, may occur for the pump 
operation if the pump speed is not suitably set [4, 5]. If the rotational speed (or pump flow) is too 
low, the blood will regurgitate from the aorta to the left ventricle through the pump (i.e. 
backflow). For this case, the cardiac output is not augmented but decreased. If the rotational 
speed is too high, the pump may attempt to draw more blood than available in the left ventricle. 
The latter will cause kinking at the connection of the left ventricle and cannula (suction) or the 
collapse of the left ventricle, which may result in damage to the heart muscle, blood, and/or 
vasculature.  
Since the LVAD is applied to unload the failing left ventricle, the basic control objective 
is to mimic the native heart function [4, 5]. From above we know that the native heart adjusts to 
the physiological cardiac output requirement by a combination of preload, contractility, afterload 
and heart rate. However, not all this information is readily available to the LVAD controller, 
especially for an ambulatory patient. Thus the main objective for the LVAD control outside the 
hospital settings is to incorporate varied and sometimes limited control inputs and to adapt the 
pump speed to the physiological state of the patient.  
This dissertation discusses a controller which will incorporate multiple hemodynamic 
variables (measured and/or estimated) and will respond to the physiological changes of the body. 
The specific inputs for the controller considered here are the heart rate and the systemic vascular 
resistance which are under the control of the baroreflex. In real life, the heart rate can be 
estimated from the electrical current to the drive motor of the LVAD and the systemic vascular 
resistance can also be estimated by using blood pressure and blood flow [10].  These will be used 
to estimate the physiological state changes and drive the pump speed toward the desired 
operating point.  
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This dissertation is organized as follows. First, in chapter 2, the LVAD control and the 
modeling of the cardiovascular system, the baroreflex and the pump are reviewed, and the 
proposed investigations and technical approaches are described.  
In chapter 3, the models of the cardiovascular system and the baroreflex are presented 
and coupled. The parameters for the healthy cardiovascular model are determined to simulate the 
normal hemodynamics. The responses to single parameter change are examined by using 
physiological simulation software as reference. The response to exercise is compared to the 
exercise experiment data in the literature. 
In chapter 4, model parameters are determined for the VAD patient with failing heart. 
Because of the progressive deterioration of the failing heart and the related cardiovascular 
system, there are some substantial changes in the cardiovascular system and the baroreflex. The 
changes in the cardiovascular system and the baroreflex are found out by surveying the literature 
and mapped to the heart failure model. 
In chapter 5, the failing heart model is coupled to the pump model and its behavior is 
examined. The simulation results are compared to the data available in the literature.  
In chapter 6, a physiological controller is developed which incorporates multiple inputs 
(heart rate and systemic vascular resistance). The heart rate and systemic vascular resistance are 
two important indicators of the physiological state of the body. Including this information will 
improve the pump control. The physiological controller is implemented and tested with the 
baroreflex + failing heart + pump model. The response to exercise of the control method is 
examined.  The performance of this controller is compared to that of other available pump 
control methods such as constant pump speed, constant pump head and heart rate related pump 
speed method. 
In chapter 7, the progress to date is concluded and future work is discussed. 
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2.0  BACKGROUND 
Basically, there are three ways of investigating the interactions between the native circulation 
and the implanted pump: simulation on model, mock circulatory system, and animal experiment. 
The mathematic model consists of abstraction of the basic circulation elements, such as the heart 
and the arterial network. The mock loop is the counterpart of a certain model by using some 
devices instead of abstraction. The animal experiment is the preclinical feasibility test of a 
certain pump or pump controller. This research is focused on the model and simulation.   
2.1 MODELING OF CARDIOVASCULAR SYSTEM, THE BAROREFLEX AND 
PUMP 
The cardiovascular system is usually modeled by using electrical network with the voltage 
representing pressure, the current representing flow and charge representing volume. The 
ventricular function and the arterial network are the two main foci of the modeling efforts. 
Generally the left ventricle is model as a time varying capacitor (or elastance) which may take 
form of exponential [11], sinusoidal [12] or double hill function [13]. There are two ways of 
modeling the arterial network: lumped and distributed system. The windkessel models are typical 
lumped system modeling of the arterial network. A variety of windkessel models have been 
developed which are basically RLC networks [14, 15]. The transmission line is a typical 
distributed system modeling of the arterial network which simulates the pressure wave as a 
function of time and location [16-18]. It is noteworthy that the parameters of the models are 
fixed.  
Besides the modeling of the heart and the arterial network, there are also efforts on 
modeling the baroreflex, the cardiovascular regulation system. The baroreflex is a built in 
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feedback system which stabilize the arterial pressure by varying the cardiac output and the 
systemic resistance. There are some pressure sensors located at the aortic arch and carotid sinus, 
which convert the pressure into nervous signal. This inbound nervous signal is then transmitted 
to the central nervous system and translated into outbound nervous signal. The outbound nervous 
signal stimulates the end organs such as the heart, the vasculature and renal system to keep the 
blood pressure equal or close to an intrinsically established setpoint.  
Models of the baroreflex can be found in [19-21]. The baroreflex in [19] is modeled as a 
static mapping between the arterial pressure and the heart rate (or the systemic vascular 
resistance). The baroreflex models in both [20] and [21] consist of the baroreceptor (pressure 
sensor), the afferent pathway, the efferent pathways, and end organs effectors. With the 
baroreflex model coupled to the cardiovascular system, the parameters of the cardiovascular 
system such as the heart rate and the systemic vascular resistance are not fixed any more but 
become pressure-dependent. 
The rotary pump model is effectively a current (blood flow) source connecting the 
ventricle to the systemic arterial system. The input of the model is the rotational speed and/or the 
electrical current. The variables that define the interface of the pump with the cardiovascular 
system are the inlet and outlet pressure, and pump flow [4, 22]. With this interface, the pump 
model can be coupled to the cardiovascular system model and used to simulate the interaction 
between the pump and the cardiovascular system and examine the performance of a control 
method.   
2.2 PREVIOUS CONTROL FOR LVAD  
The principal goal of the blood pump controller is to respond to and meet the body demand for 
cardiac output. The inputs of the controller are available hemodynamic variables of the patient 
and the output of the controller is the pump speed or electrical signals such as voltage and 
current. Figure 2.1 shows the animal experiment data with a rotary pump implanted where the 
pump speed is a ramped from 7.8 to 14.5 krpm over 150 seconds. The task of the controller is to 
provide a speed in the range of optimal zone or safe zone while avoiding suction zone or under 
pumping zone.  
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Figure 2.1. In vivo hemodynamics of calf implanted with turbodynamic LVAD  
(University of Pittsburgh, unpublished data). 
The pump speed is a ramp from 7.8 to 14.5 krpm. From left to right, the operating zones: back flow, safe, optimal 
and suction. The bottom shows traces of waveforms of pump flow for low speed, optimal speed and high speed. 
 
However, the controller development is handicapped by the limited availability of 
physiological information of the body. Early solution for the control problem was to set a 
constant speed for the LVAD and recipients were supervised in the hospital [5]. While this open-
loop method is easy to implement, the disadvantage is that once the physiological condition of 
the patient changes, the patient would be at risk of adverse phenomena such as back flow and 
suction.  
Because of the limited available information for the controller, some sensor-less methods 
for LVAD control were developed by using the pump variables such as current, voltage and 
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speed [23-26]. This technique is based on the observation that pressure across, and flow through, 
a rotary VAD can be inferred or estimated from the electrical current and frequency of the 
pump’s motor. Several other investigators have adopted a similar “sensor-less” approach to 
estimate pressure and flow [27-32]. However, these estimations and controllers are reliable only 
in a relatively narrow range of pump variables. When the pump is operating in a wide range of 
the patient’s physiological situations, these controllers may mislead the pump to hazards for the 
recipients.  
As to control strategy, one simple idea for the controller is to maximize the flow while 
avoiding suction (optimal zone in Figure 2.1). Some suction indices are based on time domain 
characteristics and frequency domain extraction from waveform of the pump flow.  The 
harmonic spectral index is one of them [26]. This method is based on the observation that high 
frequency components in pump flow or pump current increase in suction zone compared to the 
fundamental frequency component. Another method is using the pulsatility of the flow as control 
input . A method reducing the uncertainty of the suction detection was also developed . 
More generally, keeping hemodynamic variables such as the atrial pressure, the aortic pressure 
and cardiac output close to nominal values may lead to multiple objectives optimization . 
[4] [33]
[6]
Hierarchical control for LVAD, an intelligent structure based on multiple objectives optimization 
and expert system, is further discussed in [34, 35]. The main challenge for this class of methods 
is the adaptability of the suction detector if SVR changes. To further exploit the fact that the 
minimum pump flow achieves the extremum at the point of suction event (around 100s in Figure 
2.1), a controller was developed which tracks the extremum even as SVR changes . The 
disadvantage of this class of methods is that the pump speed is close to the upper bound of the 
optimal zone and thus is precariously close to suction.  
[36]
Controllers to keep the average pressure across the pump (or between the aorta and the 
left ventricle) constant have been developed in [31, 38-40]. This class of controllers can provide 
a pump speed in the safe zone or optimal zone for a certain SVR. However, the operating pump 
speed may move into the under pumping zone or suction zone if the SVR varies due to change in 
physiological state of the patient. The disadvantage for this class of methods is that these 
controllers require pressure sensors mounted at the inlet and outlet of the pump. If the use of 
pressure sensors is not practical, then the pressure difference may be estimated from the 
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rotational speed and/or the motor current by using sensor-less methods [31]. This would be 
limited by the applicable physiological range.  
An investigation using oxygen saturation of the blood for control purpose has also been 
reported . [41] In an animal experiment a proportional control law was implemented that 
increased the flow of a total artificial heart in proportion to changes in the mixed venous oxygen 
saturation (MVO2) which is acquired by an indwelling sensor. The addition of a MVO2 sensor 
would benefit the overall robustness of the controller; however changes in MVO2 are relatively 
slow, as compared to the rapid changes in vascular resistance, for example. A controller based on 
MVO2 alone would not be able to respond to the rapid physiological changes and to avoid 
suction.  
Other control approaches such as using the heart rate as a controller input have been 
reported . As one part of the circulation regulatory system, the heart rate is an indicator of 
blood flow demand of the body. In the animal experiment, the controller 
[42]
adjusted the pump 
speed in response to increasing or decreasing heart rate in a linear relationship. The HR in this 
study was calculated from the pump current. In-vivo results demonstrated a positive response of 
this control scheme to treadmill exercises. However, this method does not take the change in 
SVR into account. From rest to exercise, there is a dramatic decrease in SVR accompanying the 
increase in heart rate. For the case of heart failure where the heart is not pumping effectively, 
change in SVR is a major mechanism to generate the desired cardiac output. The controller based 
on the HR alone may fail to provide the appropriate cardiac output for the physiologically 
changing body.  
This dissertation will discuss an improved controller that incorporates the heart rate and 
the systemic vascular resistance and respond to the physiological changes of the body 
instantaneously based on the baroreflex, the built in cardiovascular regulation system. The heart 
rate can be inferred from pump current and the systemic vascular resistance can be estimated 
from blood flow and blood pressure. By incorporating the information of the heart rate and the 
systemic vascular resistance, the controller can vary the pump speed in response to the change in 
physiological state of the body, even for the challenging case of exercise. 
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2.3 THE PROPOSED INVESTIGATIONS  
The main goal of this work is to improve the LVAD support for patients with heart failure. A 
physiological control algorithm will be developed, based on the models of implanted LVAD, the 
heart, circulation and regulatory system. The underlying principle of demand based control is the 
baroreflex, the autoregulatory system of the circulation, which manages the blood pressure and 
cardiac output. For a healthy person, the baroreflex regulates the blood pressure and cardiac 
output according to different physiological states of the body by changing heart rate, heart 
contractility, systemic vascular resistance and total blood volume. For a patient with heart 
failure, the baroreflex is preserved fairly well even though some end organs functions are 
attenuated or damaged. The proposed controller will use the estimated heart rate and estimated 
systemic vascular resistance as control inputs to generate the optimal pump speed for a specific 
physiological state. 
The investigations will be based on a combination of existing theory and new models. 
The specific aims and associated technical approaches are:  
(1) To improve the combined model of the cardiovascular system and the LVAD. The 
coupled model of a LVAD and a cardiovascular system with a built in baroreflex will be 
established for simulating the interaction between the LVAD and the cardiovascular 
system and testing a physiological controller. This model will include the autoregulation 
of the cardiovascular system and the hydraulic power input from the pump. This model 
will be more realistic to simulate the interactions between the LVAD and the circulatory 
system regulated by the baroreflex.  
(2) To develop a physiological control algorithm for the LVAD that can incorporate various 
sensors inputs and/or estimations. A physiological controller for the LVAD will be 
developed which incorporates the information of heart rate and systemic resistance. This 
controller will behave like a part of the autoregulation of the cardiovascular system and 
thus will be responsive to changes in hemodynamic parameters and variables for different 
physiological states.  
(3) To implement and validate this control algorithm on the combined model of the LVAD 
and the cardiovascular system, and examine the performances of the proposed control 
algorithm by comparing to constant pump speed, constant pump head, and heart rate 
 9 
related pump speed method. The resistance of the controller to noise will also be 
examined. 














Figure 2.2. Block diagram of the proposed control scheme. 
 
The following chapters will present the up-to-date progress of the investigation, including 
the healthy and failing cardiovascular models with built in baroreflex, the combined model of the 
pump and the cardiovascular system with baroreflex, and the proposed pump controller using the 






3.0  MODEL OF HEALTHY HEART WITH BAROREFLEX 
In this chapter, the pulsatile heart model is introduced in section 3.1 first and the baroreflex 
model in 3.2. Then the two models are coupled to simulate the interaction between them. The 
parameters of the coupled model are tuned in section 3.3 by using physiological simulation 
software Simbiosys as a reference. Then the response of the coupled model to single parameter 
change in preload, afterload, left ventricular contractility and heart rate is compared to that of 
Simbiosys in section 3.3. The response of the model to exercise is also examined in section 3.4. 
3.1 THE CARDIOVASCULAR SYSTEM MODEL 
The cardiovascular system model employed here is from [43-46] which is represented by the 
lumped parameter circuit shown in Figure 3.1. Table 3.1 lists the state variables, and Table 3.2 
lists the system parameters and their associated values. 
 








Figure 3.1. Cardiovascular system model. 
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 Table 3.1. State variables 
Variables Physiological meaning (units) 
1cx  Left ventricular volume (ml)  
2cx  Left atrial pressure (mmHg)  
3cx  Arterial pressure (mmHg)   
4cx  Aortic Flow (ml/s)  
 




Resistances    
R1 Systemic Resistance   
R2 Mitral valve  0.005 mmHg/ml/s 




Compliances    





C2 Left atrial compliance 4.4 ml/mmHg 
C3 Systemic compliance 1.33  
Inertances    
L Inertance of blood in 
Aorta 
0.0005 mmHg.s2/ml 
Valves    
D1 Mitral valve   
D2 Aortic valve   
 
In this lumped parameter circuit, the left ventricle is described as a time-varying 
capacitor. One way to model its behavior is by means of the elastance function, which is the 
reciprocal of the compliance. It determines the change in pressure for a given change in volume 




( )( ) 1/ ( )
( )
LVP tE t C t
LVV t V
= =−      (3.1) 
Where E(t) is the time varying elastance (mmHg/ml), LVP(t)= x1(t) is the left ventricular 
pressure (mmHg), LVV(t) is the left ventricular volume (ml) and V0 is a reference volume (V0 = 
5 ml for a normal heart), the theoretical volume in the ventricle at zero pressure. 
The elastance function  
max min min( ) ( ) ( )n nE t E E E t E= − +     (3.2) 
Where constants Emax and Emin are related to the end systolic pressure volume relationship 
(ESPVR) and the end diastolic pressure volume relationship (EDPVR), respectively. En(tn) is 
the normalized time-varying elastance, so called “double hill” function from [13], tn = t/Tmax, 












⎡ ⎤ ⎡ ⎤⎛ ⎞⎢ ⎥ ⎢ ⎥⎜ ⎟⎝ ⎠⎢ ⎥ ⎢ ⎥= ∗ ∗⎢ ⎥ ⎢ ⎥⎛ ⎞ ⎛ ⎞+ +⎜ ⎟ ⎜ ⎟⎢ ⎥ ⎢ ⎥⎝ ⎠ ⎝ ⎠⎣ ⎦ ⎣ ⎦   (3.3) 
Notice that E(t) is a re-scaled  version of En(tn). Figure 3.2 shows the elastance function 
for Emax = 2.0, Emin = 0.06, and heart rate 60 bpm. 
 






















Figure 3.2. Typical elastance function 
Emax = 2.0, Emin = 0.06, and normalized cardiac cycle. 
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Since this model includes two diodes, the following phases will occur, over four different 
time intervals in a normal cardiac cycle, as illustrated in Table 3.3. 
 
Table 3.3. Phases in a cardiac cycle 
Modes Valves Phases 
 D1 D2  
1 Closed  Closed  Isovolumic contraction 
2 Closed  Open  Ejection 
1 Closed  Closed  Isovolumic relaxation 
3 Open Closed  Filling  
- Open  Open  Not feasible 
 
For each phase of the cardiac cycle, the state equation can be written into the form of  
( )dx A t x
dt
=       (3.4) 
with different matrix A(t) for each phase, [ ]1 2 3 4 Tc c c cx x x x x= . 
1) Isovolumic phase: In this phase of the cardiac cycle, the aortic and mitral valves are closed. 
Since the aortic valve is closed, the aortic flow is zero, i.e., 4 0cx = . In this phase, we have: 
1 2 1 2
1 3 1 3




0 0 0 0
R C R C
A t
R C R C
⎡ ⎤⎢ ⎥⎢ ⎥−⎢ ⎥= ⎢ ⎥⎢ ⎥−⎢ ⎥⎢ ⎥⎣ ⎦
    (3.5) 
2) Ejection phase: In this phase, the aortic valve is open, and the mitral valve is closed. In this 
phase the left ventricle is pumping blood into the circulatory system, where 
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1 2 1 2
1 3 1 3 3
3 4
0 0 0 1
1 10 0
( ) 1 1 10
( ) 1 ( )0
R C R C
A t
R C R C C




⎡ ⎤⎢ ⎥⎢ ⎥−⎢ ⎥⎢ ⎥= ⎢ ⎥−⎢ ⎥⎢ ⎥+⎢ ⎥− −⎢ ⎥⎣ ⎦
  (3.6) 
 
3) Filling phase: When the heart is filling, blood from the left atrium goes into the left ventricle. 





2 2 1 2 2 1 2
1 3 1 3
( ) ( ) 0 0




E t E t
R R
E t R R
R C R R C R CA t
R C R C
0
⎡ ⎤−⎢ ⎥⎢ ⎥+⎢ ⎥−⎢ ⎥= ⎢ ⎥⎢ ⎥−⎢ ⎥⎢ ⎥⎢ ⎥⎣ ⎦
   (3.7) 
The case with both valves open does not occur for a normal heart and thus is not included 
in this model. For a sequence of these phases in a normal cardiac cycle, for example, filling-
contraction-ejection-relaxation, the end states of the last phase are initial conditions for the next 
phase.  
3.2 THE BAROREFLEX MODEL 
The baroreflex model employed here is from [48-50] with some parameters tuned to simulate the 
human dynamics. In this model, the baroreflex consists of the baroreceptor, the afferent pathway, 
the efferent pathways and the regulation effectors. The baroreceptor is a pressure sensor located 
in the carotid sinus or aorta which converts pressure into afferent firing frequency. Then the 
afferent firing frequency is translated into efferent signals by the nervous system: sympathetic 
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firing frequency and vagal firing frequency. These efferent signals are the inputs of the 
regulation effectors. The regulation effects include changes in vessels resistances and heart rate 
(or cardiac cycle). For example, if the pressure is lower than the set point, the systemic resistance 
and heart rate will increase to reduce the error between the current pressure and the set point 
pressure. The closed loop baroreflex of the block diagram in Figure 3.3 is applied on the 










Figure 3.3. Block diagram for the carotid baroreflex. 
The baroreflex consists of baroreceptor, afferent pathway, efferent pathway and regulation effectors. 
 
Afferent pathway. In [48] the afferent baroreflex pathway is described as the series 
arrangement of a linear derivative first-order dynamic block and a sigmoidal function as shown 









Figure 3.4. Block diagram for the afferent pathway of carotid sinus. 
 
The linear derivative block in Figure 3.4 
in
p in z
dPdp p pdt dtτ τ= + −                                      (3.8) 
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Where pτ and zτ are the time constants for the real pole and the real zero in the linear 
dynamic block (usually with / 1z pτ τ > ), inp is the carotid sinus pressure, p is the output variable 
of the linear derivative dynamic block (with dimension of pressure). 

















      (3.9) 
where asf  is the frequency of spikes in the afferent fibers, maxf and minf are the upper and lower 
saturation of the frequency discharge,  is the value of the intrasinus pressure at the central 
point of the sigmoidal functional, is a parameter with the dimension of pressure, related to the 
slope of the static sigmoidal function at the central point. The characteristic curves for the linear 
derivative and static sigmoid functions are shown in Figure 3.5.  
oP
aK
Efferent sympathetic pathway.  The monotonically decreasing function that relates the 
activity in the afferent and efferent neural pathways is described by an exponential shaped 
function [48].  
0( ) ( )as es as
K f
es es esesff f f f e−∞ ∞= + −     (3.10) 
Where esf is the frequency of spikes in the efferent sympathetic nerves, , esK 0esf  and esf ∞  are 
constants (with 0 esesf f ∞>  ),  asf is the output in (3.9). The characteristic curve is shown in 
Figure 3.6. 
 
a. Characteristic curve (frequency domain) for afferent pathway (linear derivative).  
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b. Characteristic curve for afferent pathway (static sigmoid). 
oP  = 80 mmHg; aK  = 11.758 mmHg; minf  = 2.52 spikes/s;  = 47.78 spikes/s. maxf
 




Figure 3.6. Characteristic curve for the efferent sympathetic pathway. 
esf ∞  = 2.1 spikes/s; 0esf  = 16.11 spikes/s; esK  = 0.0675 s/spikes. 
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Efferent vagal pathway. The efferent vagal activity is a monotonically increasing 
function of the activity in the sinus nerve with an upper saturation. The sigmoidal equation 





















    (3.11) 
 
Where evf is the frequency of spikes in the efferent vagal fibers, , evK 0evf and evf ∞ are constant 
parameters (with 0ev evf f∞ > ), asof is the central value in the characteristic curve in (3.9) and 
asf is the output in (3.9). The characteristic curve is shown in Figure 3.7. 
 
 
Figure 3.7. Characteristic curve for the efferent vagal pathway. 
0evf  = 3.2 spikes/s; evf ∞  = 6.3 spikes/s; asof  = 25 spikes/s; evK  = 7.06 spikes/s. 
 
Regulation effectors 
A. Sympathetic effectors on resistances 
To simulate the blood flow distribution among the different parts of the body, the 
systemic vascular resistance is divided into three parts: 1R , 2R , 3R . 1R  is the splanchnic 
resistance;  2R  is the resistance other than active muscle and splanchnic resistance; 3R  is the 
active muscle resistance. 
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The response of the resistances to the sympathetic drive includes a delay, a logarithmic 
static function, and a low-pass first-order dynamics [48].   













− + ≥= <
      (3.12) 






dt R t e tτ
Δ −Δ +=     (3.13) 
0( ) ( )i i iR t R t R= Δ +       (3.14) 
Where iR  is the resistances with 1, 2,3i = , iRe is the output of the static logarithmic 
characteristic function,  is the value of (| t Diesf − ) esf  evaluated at ( )t Di− , Riτ and iD are the time 
constants and delay of the mechanism, is the minimum sympathetic stimulation, and minesf
( )iR tΔ is the resistance change with respect to  caused by sympathetic stimulation and  is a 
constant gain factor. 
0iR RiG
 






















x f f f
f f
⎧⎪⎨⎪⎩
− + ≥= <  
minesf = 2.66 
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B. Heart rate effectors 
The response of the cardiac cycle is a result of both the vagal and sympathetic activities. 
The cardiac cycle changes induced by sympathetic stimulation are achieved through equations 
similar to (3.12) and (3.13) [48].  
min min
min
ln[ ( ) 1]( ) 0
es esTs Ts es es
Ts
es es
G f t D f f fe t f f
⎧⎪⎨⎪⎩
− − + ≥= <       (3.15) 
 




dt Ts t e tτ
Δ −Δ +=     (3.16) 
The cardiac cycle change induced by vagal activity differs from the sympathetic case 
because cardiac cycle increases linearly with the efferent vagal excitation [48]. 
(( ) ev TvTv Tv )f t De t G −=      (3.17) 
 




dt Tv t e tτ
Δ −Δ +=     (3.18) 
Where the meanings of the symbols are similar to that of (3.12) and (3.13). 
The cardiac cycle is calculated by assuming a linear interaction between the sympathetic 
and vagal caused changes [48]. 
0( ) ( ) ( )T t Ts t Tv t T= Δ + Δ +     (3.19) 
Where  is the overall altered cardiac cycle due to sympathetic and vagal stimulation, ( )T t ( )Ts tΔ  
is the change due to sympathetic stimulation, ( )Tv tΔ  is the change due to vagal stimulation,  is 
the constant cardiac cycle without any nervous excitation. 
0T
3.3 THE COMBINED MODEL OF THE BAROREFLEX AND THE 
CARDIOVASCULAR SYSTEM 
Based on the cardiovascular model in section 3.1, the baroreflex model is coupled to it. In the 
combined model of Figure 3.9, R1 in the cardiovascular circuit model is the SVR which is 
divided into 3 parallel parts to simulate the blood flow distribution among different parts of the 
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body. The left ventricle contractility (Emax) and total blood volume (VT, summation of the 
charge in capacitors and inductors) are results of sympathetic excitation in the model. The 
arterial pressure is the input for the baroreflex. The SVR, HR, Emax and VT are under the control 
of the baroreflex. Specifically, the SVR, Emax and VT vary instantaneously; the HR (60/ cardiac 
cycle) varies cycle by cycle, in other words, the HR remains constant in a cardiac cycle. 
The hemodynimic variables generated by Simbiosys (Critical Concepts, Inc) [51] are 
used as reference for tuning the parameters for this coupled model. Simbiosys is a physiology 
simulation software which uses mathematical models to simulate the function of the heart and 










Figure 3.9. Pulsatile heart coupled with baroreflex. 
The arterial pressure is the input of the baroreflex, SVR, HR, Emax, VT  are under the control of the 
baroreflex. 
 
Table 3.4 shows the state variables for the baroreflex block and Table 3.5 parameters 
(most from [48-51]) and values for tuning the baroreflex to generate normal hemodynamics. The 
resulting steady total blood volume is about 250 ml. The SVR (R1 in the circuit) in this model is 
still divided into three parallel parts: 11R , 12R , 13R .  
 
Table 3.4. State variables for baroreflex 
1bx  the change in splanchnic resistance due to sympathetic stimulation 
2bx  the change in the resistance other than active muscle and splanchnic 
resistance due to sympathetic stimulation  
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Table 3.4. ontinued) (c
the change in active musc ympathetic stimulation le resistance due to s3bx  
4bx  the change in cardiac cycle due to sympathetic stimulation  
5bx  the change in cardiac cycle due to vagal stimulation  
6bx  the change in heart contractility due to sympathetic stimulation  




1 ( )bi bi i ci
dx
dt x u xτ += −  for 1,2,3,4,5,6,7i =     (3.20) 
























|ln[ 1g f f⎧ − +  1,2,3,4,6,7i =  (3.21) 
)d55 3 5 (
( ) |c ev tu x g f −=                    (3.22) 
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+ ∗ −+ + −=
K    (3.24) 
11 10 1bR R x= +        (3.25) 
12 20 2bR R x= +        (3.26) 
13 30 3bR R x= +        (3.27) 
5       (3.28) 
x
0 4b bT T x x= + +
0 6max max bE E= +       (3.29) 
       (3.30) 70T T bV V x= +
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Where iτ , , , , ig id minesf esf ∞ , 0esf , ,  ,esK _offset es 0evf , evf ∞ , , , evK _offset ev asof , minf , 
maxf , , , , aK oP SV 10R , 20R , 30R , , 0T minesf , , are constants, 0maxE 0TV esf is the sympathetic 
activity, evf  is the vagal activity. 
Table 3.5. Values for baroreflex parameters 
Parameter  Value Physiological meaning 
1τ  10 s Time constant for resistance 
2τ  10 s Time constant for resistance 
3τ  10 s Time constant for resistance 
4τ  4 s Time constant for sympathetic 
stimulated cardiac cycle change 
5τ  1.5 s Time constant for vagal stimulated 
cardiac cycle change 
6τ  10 s Time constant for sympathetic 
stimulated heart contractility change 
7τ  20 s Time constant for sympathetic 
stimulated total blood volume change 
1g  0.695 Gain for splanchnic resistance change 
2g  0.53 Gain for other resistance change 
3g  2.81 Gain for muscle resistance 
4g  -0.6 Gain for sympathetic stimulated 
cardiac cycle change 
5g  0.1 Gain for vagal stimulated cardiac 
cycle change 
6g  0.475 Gain for sympathetic stimulated heart 
contractility change 
7g  20 Gain for sympathetic stimulated total 
blood volume change 
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Table 3.5. (continued) 
1d  2 s Time delay for sympathetic 
stimulated resistance change 
2d  2 s Time delay for sympathetic 
stimulated resistance change 
3d  2 s Time delay for sympathetic 
stimulated resistance change 
4d  2 s Time constant for sympathetic 
stimulated cardiac cycle change 
5d  0.2 s Time constant for vagal stimulated 
cardiac cycle change 
6d  2 s Time delay for sympathetic 
stimulated heart contractility change 
7d  5 s Time delay for sympathetic 
stimulated total blood volume change 
zτ  6.37 s Constant 
pτ  2.076 s Constant  
minesf  2.66 spikes/s Threshold value for sympathetic 
excitation  
esf ∞  2.1 spikes/s Constant  
0esf  16.11 spikes/s Constant  
esK  0.0675 s/spikes Constant  
_offset es  0 spikes/s Offset in sympathetic activity 
0evf  3.2 spikes/s Constant 
evf ∞  6.3 spikes/s Constant 
evK  7.06 spikes/s Constant 
_offset ev  0 spikes/s Offset in vagal activity 
asof  25 spikes/s Constant 
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Table 3.5. (continued) 
minf  2.52 spikes/s Constant 
maxf  47.78 spikes/s Constant 
aK  11.758 mmHg Constant 
oP  92 mmHg Constant 
10R  2.49  mmHg/ml/s Constant 
20R  0.96 mmHg/ml/s Constant 
30R  4.13 mmHg/ml/s Constant 
0T  0.2 s Constant 
0maxE  2.2 mmHg/ml Constant 
0TV   205 ml  Constant 
 
The baseline P-V loops for Simbiosys and the model are shown in Figure 3.10 and the 
waveforms of left ventricular pressure and left ventricular volume are shown in Figure 3.11. 
Table 3.6 lists the baseline hemodynamics for both the model and Simbiosys. It can be seen that 
the model reproduces fairly well the baseline hemodynamics generated by Simbiosys. 
 
 




b. P-V loop generated by the model. 
 










b. Left ventricular pressure and left ventricular volume generated by the model. 
 
Figure 3.11. Left ventricular pressure and left ventricular volume. 
 
Table 3.6. Baseline Hemodynamics 
Simbiosys Model 
LVEDP (mmHg) 7 LVEDP (mmHg) 7 
LVESP (mmHg) 90 LVESP (mmHg) 89 
EDV (ml) 118 EDV (ml) 121 
ESV (ml) 40 ESV (ml) 44 
MAP (mmHg) 88 MAP (mmHg) 89 
SV (ml) 78 SV (ml) 77 
HR (bpm) 68 HR (bpm) 69 
CO (l/min) 5.3 CO (l/min) 5.3 
LV contractility 1.03 Emax (mmHg/ml) 2.7 
Arterial contractility 1.16 SVR (mmHg/ml/s) 0.91 
Sympathetic tone 0.137 Sympathetic activity 2.78 
Parasympathetic tone 0.360 Parasympathetic activity 6.11 
LVEDP: left ventricular end diastolic pressure; LVESP: left ventricular end systolic pressure; EDV: end diastolic 
volume; ESV: end systolic volume; MAP: mean arterial pressure; SV: stroke volume; HR: heart rate; CO: cardiac 
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output; Emax: peak left ventricular contractility; SVR: systemic arterial resistance. Sympathetic activity and 
parasympathetic activity are in mean value (spikes/s). LVESP for Simbiosys is read directly from the panel; LVESP 
for the model is hard to read thus assumed the same as MAP. The values for LV contractility, arterial contractility 
are dimensionless relative parameters (needed to be multiplied by a constant contractility); sympathetic tone and 
parasympathetic tone are dimensionless parameters range from 0 (no tone) to 1 (maximum tone). 
3.4 RESPONSE TO SINGLE PARAMETER CHANGE 
The behaviors of the model and Simbiosys are compared by examining the response of the both 
to single parameter change in preload, afterload, left ventricular contractility and heart rate.  
3.4.1 Response to decrease in preload (blood withdrawal) 
This subsection will examine the response of the model to forced change in preload by using 
blood withdrawal. The percentage of blood loss is set the same for Simbiosys and the model. For 
example, for the normal value of total blood volume 5000 ml, -500 ml implies 10 % loss of 
blood in Simbiosys. Similarly, for the model with total blood volume of 250 ml, -25 ml implies 
10% loss of blood. The maximum available withdrawal rate 10000 ml/hr (or 2.78 ml/s) in 
Simbiosys is used to avoid fluid compensation from the renal system. For the model, the rate of 
bleeding is the same by decreasing the left ventricular volume. The steady state values are 
recorded in Table 3.7 after the desired loss of blood is finished. P-V loops are shown in Figure 
3.12 for 20% loss of blood. Figure 3.13 shows the changes in hemodynamic variables compared 
with corresponding baseline values. 
 
Table 3.7. Response to change in preload 
 Hemodynamics Baseline 10% loss 
of blood 
20% loss of 
blood 
Tendency 
LVEDP (mmHg) 7 4 0 Down  
LVESP (mmHg) 90 87 82 Down 
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Table 3.7. (continued) 
 EDV (ml) 118 104 78 Down 
 ESV (ml) 40 37 33 Down 
 MAP (mmHg) 88 86 85 Down 
 SV (ml) 78 67 45 Down 
 HR (bpm) 68 74 98 Up  
Simbiosys CO (l/min) 5.3 5.0 4.4 Down 
 LV contractility 1.03 1.05 1.06 Up  
 Arterial contractility 1.16 1.22 1.31 Up  
 Sympathetic tone 0.137 0.185 0.256 Up  
 Parasympathetic tone 0.360 0.360 0.268 Down 
 LVEDP (mmHg) 7 6 5 Down 
 LVESP (mmHg) 89 85 81 Down 
 EDV (ml) 121 102 83 Down 
 ESV (ml) 44 40 35 Down 
 MAP (mmHg) 89 85 81 Down 
Model SV (ml) 77 62 48 Down 
 HR (bpm) 69 76 86 Up 
 CO (l/min) 5.3 4.7 4.1 Down 
 Emax (mmHg/ml) 2.7 2.8 3.0 Up  
 SVR (mmHg/ml/s) 0.91 0.98 1.1 Up  
 Sympathetic activity 2.78 2.80 2.86 Up  





a. 20% Blood withdrawal for Simbiosys. 
 
b. 20% Blood withdrawal for the model. 


























b. 20 % loss of blood. 
 
Figure 3.13. Changes in hemodynamics for loss of blood. 
With loss of blood, CO and MAP decrease; HR, SVR, and Emax increase. 
 
 
For both Simbiosys and the model, when preload decreases, (1) P-V loops shrink towards 
the left bottom corner of the coordinate; (2) stoke volume decreases and heart rate increases but 
cardiac output decreases; (3) mean arterial pressure decreases even though systemic vascular 
resistance increases; (4) left ventricular contractility and sympathetic activity increases, 
parasympathetic activity decreases. 
3.4.2 Response to change in afterload (SVR) 
This subsection will examine the response of the model to forced change in afterload by using 
forced change in SVR. The change in SVR for Simbiosys is induced by forced change in arterial 
contractility. For the model, it is induced by forced change in SVR directly. The steady state 
values are recorded in Table 3.8 after the changes. P-V loops in Figure 3.14 and Figure 3.15 are 
shown respectively for -20% and +20% change in SVR for Simbiosys and the model. Figure 




a. -20% in SVR for Simbiosys. 



























b. -20% in SVR for the model. 








b. +20% in SVR for the model. 
 
Figure 3.15. Change in P-V loop for +20% in SVR. 
 














LVEDP (mmHg) 5 6 7 7 7 Up 
LVESP (mmHg) 84 87 90 92 93 Up 
EDV (ml) 111 116 118 119 119 Up  
ESV (ml) 35 38 40 42 44  Up  
MAP (mmHg) 85 87 88 89 90 Up  
SV (ml) 76 78 78 77 75 Down 
HR (bpm) 85 75 68 64 60 Down 
CO (l/min) 6.5 5.9 5.3 4.9 4.5 Down 
LV contractility 1.07 1.05 1.03 1.03 1.03 Down 
Arterial 
contractility 
0.87 1.02 1.16 1.26 1.40 Up  









Parasympathetic  0.360 0.360 0.360 0.360 0.360 same 
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Table 3.8. (continued) 
LVEDP (mmHg) 7 7 7 7 7 same 
LVESP (mmHg) 89 89 89 89 89  
EDV (ml) 129 125 121 117 113 Down 
ESV (ml) 43 44 44 45 45 Up  
MAP (mmHg) 89 89 89 89 89  
SV (ml) 86 81 77 72 68 Down 
HR (bpm) 75 72 69 67 66 Down 
CO (l/min) 6.4 5.8 5.3 4.9 4.4 Down 
Emax 
(mmHg/ml) 
2.8 2.8 2.7 2.7 2.6 Down 
SVR 
(mmHg/ml/s) 
0.73 0.82 0.91 1.0 1.1 Up  
Sympathetic 
activity 





















a. -20 % in SVR. 










b. +20 % in SVR. 
HR, CO and Emax decrease with increase in SVR. 
 
Figure 3.16. Changes in hemodynamics for changes in SVR. 
 
For both Simbiosys and the model, when afterload increases, (1) P-V loops do not change 
greatly; (2) stroke volume, heart rate and cardiac output decrease; (3) mean arterial pressures do 
not increase greatly; (4) left ventricular contractility (or Emax) and sympathetic activity 
decrease. The difference is that: when afterload increases, the parasympathetic tone does not 
change in Simiosys, but it increases in the model. 
3.4.3 Response to change in left ventricular contractility (or Emax) 
This subsection will examine the response of the model to forced change in left ventricular 
contractility by using forced change in Emax. The change in Emax for Simbiosys is induced by 
forced change in left ventricular contractility. For the model, it is induced by forced change in 
Emax directly. The steady state values are recorded in Table 3.9 after the changes. P-V loops in 
Figure 3.17 are shown +40% for change in left ventricular contractility for Simbiosys and +40% 
changes in Emax for the model. Figure 3.18 shows the changes in hemodynamic variables 




a. +40% change in left ventricular contractility for Simbiosys. 
 
b. +40% change in Emax in the model. 
 
Figure 3.17. Change in P-V loop for +40% in Emax in the model. 
 
Table 3.9. Response to change in left ventricle contractility 









LVEDP (mmHg) 7 6 5 Down 
LVESP (mmHg) 90 91 92 Up  
EDV (ml) 118 113 110 Down 
ESV (ml) 40 35 30 Down 
MAP (mmHg) 88 88 89 Up  
 
SV (ml) 78 78 80 Up  
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Table 3.9. (continued) 
 HR (bpm) 68 67 67 Down 
 CO (l/min) 5.3 5.2 5.4  
Simbio 
sys 
LV contractility 1.03 1.20 1.40 Up  
 Arterial contractility 1.16 1.16 1.15 Down 
 Sympathetic tone 0.137 0.134 0.131 Down 
 Parasympathetic tone 0.360 0.360 0.360 Same 
 LVEDP (mmHg) 7 7 7 Same 
 LVESP (mmHg) 89 90 92 Up  
 EDV (ml) 121 119 117 Same  
 ESV (ml) 44 39 33 Down 
Model MAP (mmHg) 89 90 92 Up  
 SV (ml) 77 80 84 Up 
 HR (bpm) 69 68 67 Down 
 CO (l/min) 5.3 5.5 5.6 Up 
 Emax (mmHg/ml) 2.7 3.24 3.78 Up 
 SVR (mmHg/ml/s) 0.91 0.90 0.88 Down 
 Sympathetic activity 2.78 2.78 2.76 Down  











Figure 3.18. Changes in hemodynamics for +40 % in Emax. 
MAP and CO increase; HR and SVR decrease with increase in Emax. 
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 For both Simbiosys and the model, when left ventricular contractility (or Emax) 
increases, (1) P-V loops expand to the left; (2) stoke volume increases and heart rate decreases; 
(3) systemic vascular resistance decreases; (4) sympathetic activity decreases.  
3.4.4 Response to change in heart rate  
This section will examine the response of the model to forced change in heart rate by using 
forced change in heart rate (to simulate drug intervention). The forced change in heart rate for 
Simbiosys is induced by forced change in sinus rate. For the model, it is induced by forced 
change in heart rate directly. The steady values are recorded in Table 3.10 after the changes. P-V 
loops in Figure 3.19 are shown for -10% changes in heart rate for Simbiosys and the model. P-V 
loops in Figure 3.20 are shown for +40% changes in heart rate for Simbiosys and the model. 











b. -10% change in heart rate for the model. 
 










b. +40% change in heart rate for the model. 
Figure 3.20. Change in P-V loop for +40% in HR. 
 

















8 7 6 5 4 Down 
LVESP 
(mmHg) 
91 90 89 88 86 Down 
EDV (ml) 122 118 114 110 103 Down 
ESV (ml) 41 40 39 38 37 Down 
MAP 
(mmHg) 
87 88 88 89 90 Up   
SV (ml) 81 78 75 72 66 Down 
HR (bpm) 61 68 75 82 95 Up 











1.04 1.03 1.03 1.03 1.02 Down 
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Table 3.10. (continued) 
Arterial 
contractility 
1.21 1.16 1.10 1.05 0.98 Down 
Sympathetic 
tone 




0.359 0.360 0.360 0.360 0.360 Same  
LVEDP 
(mmHg) 
7 7 7 7 6 Down 
LVESP 
(mmHg) 
90 89 89 88 89  
EDV (ml) 126 121 115 111 104 Down 
ESV (ml) 44 44 44 44 44 Same  
MAP 
(mmHg) 
90 89 89 88 88 Up 
SV (ml) 82 77 71 67 60 Down 
HR (bpm) 62 69 76 83 97 Up 
CO (l/min) 5.1 5.3 5.4 5.6 5.8 Up 
Emax 
(mmHg/ml) 
2.8 2.7 2.7 2.6 2.6 Down 
SVR 
(mmHg/ml/s) 





























Figure 5.15a -10 % in HR. 














Figure 5.15b +40 % in HR. 
CO increases; SVR and Emax decrease with increase in heart rate. 
 
Figure 3.21. Changes in hemodynamics for change in HR. 
 
For both Simbiosys and the model, when heart rate increases, (1) P-V loops shrink to the 
left; (2) left ventricular contractility decreases; (3) stoke volume decreases but cardiac output 
increases; (4) systemic vascular resistance decreases; (5) mean arterial pressure does not increase 
greatly; (6) sympathetic activity decreases. The difference is that: when heart rate increases, the 
parasympathetic tone does not change in Simbiosys, but parasympathetic activity increases in the 
model.   
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3.5 RESPONSE TO EXERCISE 
This section will examine the response of the model to exercise. The exercise level is determined 
by the combination of nervous offsets (central command) and forced change in active muscle 
resistance. The exercise experiment hemodynamic data for healthy people (9 subjects) from [52] 
are used as reference for tuning the combinations. The simulation results are compared to the 
data from [52]. 
3.5.1 Single level exercise  
In the simulation of a certain level of exercise, the set point change is induced by adding offsets 
to efferent pathways progressively, by changing the sympathetic offset  in (3.23) and 
the vagal offset in (3.24) linearly in 5 seconds. In Figure 3.22, the offsets start 




starts decreasing due to local mechanism in active muscle (forced change from 7.1 mmHg/ml/s 
to 0.8 mmHg/ml/s linearly in 10 seconds), but heart rate and left ventricle contractility increase 
continually until they achieve new steady values. The complex of changes is shown in Figure 
3.22. The new set point consists of higher pressure, higher heart rate and lower SVR which is 
consistent with exercise physiology [53]. 
 
Table 3.11. Offsets in sympathetic and vagal activity 
 Rest (steady) Exercise (steady) 
_offset es  0 0.24 
_offset ev  0 0.2 
 
As shown in Figure 3.23, the changes in P-V loops from rest to exercise include increases 
in end diastolic volume and end systolic pressure. The hemodynamic changes are listed in Table 
3.12. Since the blood flow is inverse proportional to resistance, the changes in resistances imply 
the redistribution of the blood flow. The redistribution of blood flow is shown in Table 3.13.  
 44 
































Time (seconds)  
 
Figure 3.22. Response to exercise. 
MAP in mmHg, AF (aortic flow) in L/min, HR in bpm, SVR in mmHg/ml/s, (MAP, CO, SVR) changes 
from (89, 5.3, 0.91) to (106, 10.8, 0.51) during exercise. 
 






























Figure 3.23. P-V loops of rest and exercise. 




Table 3.12. Hemodynamic changes 
Experiment data  
from [52]
Rest  Exercise  Tendency 
MAP (mmHg) 86± 3 96± 3 Up 
HR (bpm) 68± 4 111± 4 Up 
SV 93± 6 114± 8 Up  
CO (l/min) 6.2± 0.4 12.8± 1.2 Up 
SVR* (mmHg/ml/s) 0.811 0.451 Down 
LVR** (mmHg/ml/s)  0.77  
SVR/LVR (%)  58.6  
Simulation results Rest  Exercise  Tendency 
LVEDP (mmHg) 7 6 Down  
LVESP (mmHg) 89 106 Up 
EDV (ml) 121 140 Up  
ESV (ml) 44 42 Down  
MAP (mmHg) 89 106 Up 
SV (ml) 77 98 Up  
HR (bpm) 69 110 Up 
CO (l/min) 5.3 10.8 Up 
Emax (mmHg/ml) 2.7 3.3 Up  
SVR (mmHg/ml/s) 0.91 0.51 Down 
Sympathetic activity 2.77 2.92 Up  
Parasympath activity 6.12 5.97 Down  
*: calculated from systemic vascular conductance. 







Table 3.13. Changes in resistances 
Resistance  Rest Exercise 
11R  3.2 4.1 
12R  1.5 2.2 
13R  7.1 0.8 
SVR 0.91 0.51 
 
3.5.2 Multiple levels of exercise  
Multiple exercise levels are simulated by using the experimental data from [52] as reference to 
tweak the combinations of nervous offsets and forced change in 13R  (muscle resistance) to make 
the hemodynamic variables in the simulation close to the real data. The simulation results are 
shown in Table 3.14. The hemodynamic changes in percentage from rest to different levels of 
exercise (ratio of exercise to rest) are illustrated in Figure 3.24, compared to that of experiment 
data from [52].  
 
Table 3.14. Multiple exercise levels  
Exercise level 0 1 2 3 
Data from [52]
(9 subjects) 
Rest 71 w 97 w 125 w 
MAP (mmHg) 86 3 ± 96± 3 98± 3 107 2 ±
HR (bpm) 68 4 ± 111± 4 131± 4 149 3 ±
SV (ml) 93 6 ± 114± 8 114± 6 118 6 ±
CO (L/min) 6.2 0.4 ± 12.8± 1.2 14.9± 0.9 17.6 0.8 ±
SVR* 
(mmHg/ml/s) 
0.811 0.451 0.390 0.361 
LVR** 
(mmHg/ml/s) 
 0.77 0.6 0.6 
SVR/LVR (%)  58.6 65.0 60.0 
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Table 3.14. (continued) 
Simulation  
result 
0 1 2 3 
Offsets 
(O1,O2)*** 
(0,0) (0.24,0.2) (0.30,0.24) (0.33,0.24) 
MAP (mmHg) 89 106 115 116 
HR (bpm) 69 110 131 148 
SV (ml) 77 98 94 91 
CO (L/min) 5.3 10.8 12.3 13.5 
SVR 
(mmHg/ml/s) 
0.91 0.51 0.48 0.44 
R13 
(mmHg/ml/s) 
7.1 0.8 0.7 0.6 
SVR/R13 (%) 12.7 63.8 68.4 72.4 
*: calculated from systemic vascular conductance. 
**: leg vascular resistance, also calculated from systemic vascular conductance. 






































Exercise level 3 
 
Figure 3.24. Hemodynamic changes from rest to exercice. 
MAP, CO, and HR increase SVR decreases. 
 
According to exercise physiology [52-54], for the human exercise experiment, there is an 
increase in stroke volume (SV) accompanying the increase in blood pressure at low level 
excercise, and stroke volume reaches a plateau at a submaximal exercise level. Other 
hemodanymic variables (MAP, HR, CO) increase with exercise levels. To demonstrate the trends 
in hemodynamics with exercise intensity, comparable exercise experimental data from [54] are 
listed in Table 3.15. The experiment data in Table 3.14 and Table 3.15 from [52, 54] and 
simulation results for multiple exercise levels are illustrated in Figure 3.25. 
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Table 3.15. Exercise experiment data 
Exercise level 0 1 2 3 
MAP (mmHg) 98 107 112 122 
HR (bpm) 75 101 114 132 
SV (ml) 75 96 96 97 
CO (L/min) 5.4 9.8 12.0 14.2 
SVR(mmHg/ml/s) 1.0 0.65 0.55 0.5 
Data read from figures in [54]. 
 



















































Figure 3.25. Changes in hemodynamics for multiple exercise levels. 





The cardiovascular system model is described and the baroreflex model is coupled to it. Using 
physiological simulation software Simbiosys and exercise experiment data in the literature as 
reference, the coupled model of the cardiovascular system and the baroreflex reproduced the 
hemodynamic response fairly well to single parameter change in preload, afterload, left 
ventricular contractility and heart rate. The responses to multiple levels of exercise are simulated 
and the results are consistent with exercise experiment data.  Thus this coupled model can be 
considered as a model for a healthy person. The next chapter is to determine the parameters for 






4.0  FAILING HEART WITH BAROREFLEX 
In this chapter, the qualitative and quantitative changes in the cardiovascular system and the 
baroreflex will be found out by surveying the literature for patients with heart failure, and these 
changes will be mapped into the model.  The parameters are tuned by using heart failure 
hemodynamic data in the literature as reference. The responses of the model to multiple levels of 
exercise are examined and compared to that in the literature. 
4.1 HEART FAILURE AND ASSOCIATED PHYSIOLOGICAL CHANGES 
 
Heart failure is the inability of the heart to supply adequate blood flow and therefore oxygen 
delivery to peripheral tissues and organs. Heart failure is the final result of a variety of primary 
cardiovascular diseases [1]. The common cause of heart failure is coronary artery disease (CAD). 
CAD reduces coronary blood flow and oxygen delivery to the myocardium and thus causes 
impaired function. Another common cause of heart failure is myocardial infarction which needs 
to be compensated by non-infarcted regions for the loss of function. The other factors like 
valvular disease and congenital defects place increased demands upon the ailing heart and 
precipitate failure. External factors for heart failure include increased afterload and increased 
body demands. There are a series of changes associated with heart failure which include the 
changes in the cardiovascular system and the changes in the baroreflex [1, 55]. 
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4.1.1 Changes in cardiovascular system 
1) Cardiac Changes 
The changes in cardiac function associated with heart failure result in a decrease in stroke 
volume as well as cardiac output.  The decline in stroke volume is due to systolic dysfunction, 
diastolic dysfunction, or a combination of the two [1, 55]. Simply stated, systolic dysfunction is 
the result of decreased left heart contractility. Diastolic dysfunction means that the ventricle 
becomes less compliant and impairs ventricular filling.  As illustrated in Figure 4.1, the systolic 
dysfunction is usually caused by the dilated myocardium, which is characterized by increased 
end diastolic volume and decreased ejection fraction. The diastolic dysfunction is usually caused 
by the hypertrophic myocardium, which is characterized by decreased end diastolic volume.  
 
2) Neurohumoral Changes 
Neurohumoral responses include increased sympathetic nervous activities and increased release 
of antidiuretic hormone. The net effect of these neurohumoral responses is to help maintain 
arterial pressure and increase heart rate and blood volume.  Otherwise, the arterial pressure will 
drop out of acceptable range due to decreased stroke volume and cardiac output.  
 
3) Systemic Vascular Resistance changes 
To compensate for reduced cardiac output associated with heart failure, some feedback 
mechanisms within the body will try to maintain normal arterial pressure by constricting arterial 
resistance vessels thus increase the systemic vascular resistance. The baroreflex is an important 
component of this feedback system.   
 
4) Blood Volume changes 
In heart failure, the compensatory increase in blood volume can increase ventricular preload and 
stroke volume. Blood volume is augmented by decreased urine output and retention of fluid. 
There is also an increase in circulating anti-diuretic hormone that contributes to renal retention of 
water. The resulting increase in blood volume helps to maintain cardiac output. On the other 
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hand, the increased volume can be deleterious because it increases venous pressures and leads to 
pulmonary and systemic edema.  
 
 
Figure 4.1. Systolic dysfunction and diastolic dysfunction (Adopted from [56]). 
 
4.1.2 Changes in baroreflex 
Initially, a reduction in cardiac output associated with heart failure leads to a decrease in the 
arterial pressure applied to the baroreceptors which, in turn, cause increased heart rate and 
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systemic vascular resistance through sympathetic and vagal systems. The sympathetic excitation 
is in effect for the duration of the failure [57]. 
In neck chamber experiment for examining carotid baroreceptor-cardiac reflex 
mechanisms in patients with congestive heart failure, the shape of the sigmoid baroreceptor 
stimulus-cardiac response relation is qualitatively normal in heart failure patients and the time 
delay of the baroreflex is not changed, but the baroreflex sensitivity is depressed [58]. It was 
reported that there was a diminished sensitivity of the afferent limb while the gain of the central 
portion of the reflex was normal in rats with cardiac failure [59]. Patients with heart failure have 
increased sympathetic nerve activity. In addition, the increase in sympathetic activity is well 
related to severity of the heart failure and the sympathetic nerve activity progressively increases 
from mild to severe heart failure [60]. It is suggested that the depressed end-organ response of 
the baroreflex and the blunted response at the receptor level account for the decrease in 
baroreflex gain [61, 62]. It has been reported that the vasodilatory response is impaired in 
patients with congestive heart failure [63]. Reduced baroreflex sensitivity for heart failure is well 
known where baroreflex sensitivity is defined as the ratio of change in cardiac cycle to change in 
the arterial pressure [64-66].  
In summary, there are some changes in the cardiovascular system and the baroreflex with 
heart failure. These changes can be mapped into the changes in parameters of the heart failure 
model. The tendencies of parameters changes for heart failure model are listed in Table 4.1. The 
parts with parameter change in the baroreflex loop are illustrated in Figure 4.2. 
 
Table 4.1. Changes in parameters of the heart failure model 
 Parameters  Tendency  
Emax Down 
Emin Up  




Heart rate  Up  
Baroreceptor sensitivity Down  
Sympathetic heart rate gain Down 
Paraympathetic heart rate gain Down 
 
Baroreflex  
Resistances gains Down 
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Figure 4.2. Changes in baroreflex. 
The baroreceptor gain, and regulation effectors gains (sympathetic heart rate and parasympathetic gain, 
resitances gains) decrease for patients with heart failure.     
4.2 EFFECTS OF CHANGES IN HEART FOR HEART FAILURE MODEL  
The change in heart contractility and/or compliance is the primary change of heart failure. As 
shown in Figure 4.3, the left ventricular contractility (Emax) refers to the slope of end systolic 
pressure volume relationship (ESPVR) and the left ventricular compliance (1/Emin) refers to the 
reciprocal of the slope of end diastolic pressure volume relationship (ESPVR). There are 
basically two types of physical changes with heart failure: decrease in the left ventricular 
contractility and decrease in the left ventricular compliance. The change in ejection fraction 
(defined as the ratio of stroke volume to the end diastolic volume) is usually a result of the 
systolic dysfunction. In the following examples, it is assumed that change in heart contractility 
and/or compliance is the only change and other parameters (heart rate, systemic vascular 




Figure 4.3. Left ventricle pressure volume loop (adopted from [55]). 
Four phases in a cardiac cycle: a. filling, b. isovolumetric contraction, c. ejection, d. isovolumetric 
relaxation. EDV: end diastolic volume. ESV: end systolic volume. SV: stroke volume, the difference between EDV 
and ESV.  
4.2.1 Systolic dysfunction: decrease in Emax   
As shown in Figure 4.4, the slope of the end systolic pressure volume relationship (ESPVR) 
decreases with loss of left ventricular contractility (Emax). This causes an increased end systolic  
 
 
Figure 4.4. Systolic dysfunction (adopted from [55]). 
Emax decreased (loss of contractility), Emin and heart rate unchanged. 
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volume and an increased end diastolic volume; however the increase in end diastolic volume is 
not as great as the increase in end systolic volume. Thus the resulting stroke volume decreases. 
Since stroke volume decreases and end diastolic volume increases, there is a decrease in ejection 
fraction (EF). 
4.2.2 Diastolic dysfunction: increase in Emin   
As shown in Figure 4.5, a decrease in ventricular compliance (increase in Emin) accompanies 
with diastolic dysfunction, as occurs in ventricular hypertrophy. This will result in a decreased 
end diastolic volume and a greater end diastolic pressure as shown by changes in the ventricular 
pressure-volume loop. As a result of these changes, stroke volume decreases. Dependant on the 
relative change in stroke volume and end diastolic volume, there may or may not be a small 
change in ejection fraction. 
 
 
Figure 4.5. Diastolic dysfunction (adopted from [55]). 
Emin increased, Emax and heart rate unchanged. 
4.2.3 Combination of systolic dysfunction and diastolic dysfunction: decrease in Emax 
and increase in Emin 
As shown in Figure 4.6, the slope of the ESPVR is decreased (Emax decreased) and the slope of 
the passive filling curve is increased (Emin increased). There is a significant decrease in stroke 
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Figure 4.6. Combination of systolic dysfunction and diastolic dysfunction (adopted from [55]). 
Emax decreased, Emin increased and heart rate unchanged. 
4.3 DETERMINE THE PARAMETERS OF HEART FAILURE MODEL 
The parameters for heart failure model are tuned by using heart failure hemodynamic data in the 
literature as reference. These changes are made according to section 4.1 including both the 
cardiovascular model and the baroreflex model. 
 
1) Hemodynamic data for heart failure in the literature 
The hemodynamics data for patients with heart failure in [67-69] are listed in Table 4.2 as 
reference for tuning the parameters of heart failure model. These data of heart failure was 
collected before the implants of LVADs.  
 
Table 4.2.  Clinical hemodynamics data for heart failure 
Hemodynamic  Data from [67]





Systolic pressure (mmHg) 100.6± 12.4 No 97 11 ±
Diastolic pressure (mmHg) 56.8± 10.4 No 59 12 ±
 59 
Table 4.2. (continued) 
Mean arterial pressure 
(mmHg) 
74.8± 10.7 79.8± 11.4 
 
No 
Systemic vascular resistance 
(mmHg/ml/s) 
1.20± 0.32 0.93± 0.25 No 
Heart rate (bpm) 89.1± 17.6 No 103 14 ±
Cardiac output (L/min) 3.54± 0.48* 4.1± 2.0 4.6 1.4* ±
Left ventricle end diastolic 
volume (ml) 
No 241± 67 No 
Left ventricle end systolic 
volume (ml) 
No 173± 28 No 
Ejection fraction (%) No 17± 5.7 17.2 5.8 ±
*: calculated by assuming body surface area = 2 , original data are in cardiac output index 
(cardiac output normalized by the body surface area).  
2m
 
2) Tune the parameters of heart failure model 
Based on the model for healthy people, the parameters of heart failure model are tuned by using 
the clinical data in Table 4.2 as reference, according to the changes in section 4.1. The changes 
in parameters for the baroreflex of heart failure model are listed in Table 4.3.  
 
Table 4.3. Parameters for the heart failure baroreflex 
Parameter Meaning  Healthy people People with 
heart failure 
aK  1/Baroreceptor sensitivity 
 
 11.758 14 
1g  Splanchnic resistance  
effector gain 
0.695 0.63 
2g  The rest resistance 
effector gain 
0.53 0.48 
3g  Muscle resistance 
effector gain 
2.81 2.3 
4g  Sympathetic heart rate 
gain 
-0.6 -0.4 




4.4 SIMULATIONS RESULTS OF HEART FAILURE MODEL 
For different types of heart failure, realistic heart failure hemodynamics can be reproduced with 
simulations by simultaneously changing Emax, Emin,  and  (total blood volume) oV TV [70]. 
Based on the heart failure model, systolic dysfunction is simulated by decreased constant value 
of Emax and diastolic dysfunction by increased constant value of Emin. In other words, Emax is 
not under the control of the baroreflex any more due to impaired heart muscle for the case of 
systolic dysfunction. As shown in Table 4.4, two combinations of and  are simulated. As 




Table 4.4. Heart failure model combinations 
Variable or Parameter Healthy heart Heart failure 1 Heart failure 2 
oV  (ml) 5 5 35 
TV  (ml) 250 275 300 
 
To demonstrate the differences between heart failure model with baroreflex and the case 
without baroreflex, the simulation results of heart failure without baroreflex are presented and 
compared to the case with baroreflex. For the case of heart failure with baroreflex, the heart rate 
and systemic vascular resistance are still under the control of the baroreflex; for the case of the 
heart failure without baroreflex, the values of heart rate and systemic vascular resistance are the 
same as that of the healthy heart, the total blood volume is the same as the steady total blood 
volume for the heart failure with baroreflex. 
 
4.4.1 Simulation result 1 (  = 5 ml, = 275 ml) oV TV
The P-V loops for different types of heart failure are shown in Figure 4.7, Figure 4.8 and Figure 
4.9. The corresponding hemodynamics data are listed in Table 4.5. The changes in 
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hemodynamics in the simulations with respect to that of the healthy heart are shown in Figure 
4.10. 
 
1) Systolic dysfunction 
As shown in Figure 4.7, the systolic dysfunction is simulated by reduced Emax = 1.2 
mmHg/ml (normal value 2.7 mmHg/ml). The steady total blood volume for both cases is 275 ml. 
= 210 ml. The P-V loops for failing hearts shift to the right and the ejection fractions 
decrease which is the same as that in subsection 4.2.1. The case of heart failure with baroreflex 
has less end diastolic volume and less stroke volume than that of the case without baroreflex, but 
higher end systolic pressure.  
0TV
 
2) Diastolic dysfunction 
As shown in Figure 4.8, the diastolic dysfunction is simulated by increased Emin = 0.2 
mmHg/ml (normal value 0.06 mmHg/ml). = 225 ml. The P-V loops for failing hearts shift to 
the left which is the same as that in subsection 4.2.2. The case of heart failure with baroreflex has 
less end diastolic volume and less stroke volume than that of the case without baroreflex, but 
higher end systolic pressure.  
0TV






























Figure 4.7. P-V loops for healthy heart and systolic dysfunction heart. 
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Figure 4.8. P-V loops for healthy heart and diastolic dysfunction heart. 
 
3) The combination of systolic dysfunction and diastolic dysfunction 
As shown in Figure 4.9, the combination of systolic dysfunction and diastolic dysfunction 
is simulated by the combination of Emax = 1.4 and Emin = 0.2 mmHg/ml. = 190 ml. The P-
V loops for failing hearts shrink towards the center of the healthy one and the ejection fractions 
decrease which is the same as that in section 4.2.3. The case of heart failure with baroreflex has 
less end diastolic volume and less stroke volume than that of the case without baroreflex, but 
higher end systolic pressure. 
0TV
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Figure 4.9. P-V loops for healthy and the combination of both failure cases. 
 
Table 4.5. Simulation results for heart failure (1) 
















DP(mmHg) 72 71 73 71 56.8 10.4 ±
SP(mmHg) 108 97 100 85 100.6 12.4 ±
LVEDP (mmHg) 7 8 18 18 No  
LVESP (mmHg) 89 84 87 79 No  
MAP (mmHg) 89 84 87 79 74.8 10.7 ±
EDV (ml) 121 135 92 96 No 
ESV (ml) 44 87 41 67 No  
SV (ml) 77 48 51 28 No 
EF (%) 63.6 35.4 56.7 29.2 No  
HR (bpm) 69 92 86 107 89.1 17.6 ±
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Table 4.5 (continued) 
HR (bpm) 69 92 86 107 89.1 17.6 ±
CO (l/min) 5.3 4.4 4.4 3.0 3.54 0.48 ±
SVR 
(mmHg/ml/s) 
0.91 1.01 0.91 1.17 1.20 0.32 ±
Emax 
(mmHg/ml) 
2.7 1.2 2.8 1.4 No 
Emin (mmHg/ml) 0.06 0.06 0.2 0.2 No 
Sympatheteic 
activity 
2.77 2.84 2.80 2.92 No 
Parasympath 
activity 

















DP (mmHg) 72 62 67 57 56.8 10.4 ±
SP (mmHg) 108 100 101 83 100.6 12.4 ±
LVEDP (mmHg) 7 8 18 20 No  
LVESP (mmHg) 89 82 86 71 No  
MAP (mmHg) 89 82 86 71 74.8 10.7 ±
EDV (ml) 121 149 99 107 No 
ESV (ml) 44 85 40 63 No  
SV (ml) 77 64 59 44 No 
EF (%) 63.6 42.9 59.1 41.3 No  
HR (bpm) 69 69 69 69 89.1 17.6 ±
CO (l/min) 5.3 4.4 4.1 3.0 3.54 0.48 ±
SVR 
(mmHg/ml/s) 
0.91 0.91 0.91 0.91 1.20 0.32 ±
Emax 
(mmHg/ml) 
2.7 1.2 2.7 1.4 No  
Emin (mmHg/ml) 0.06 0.06 0.2 0.2 No  
DP: diastolic pressure; SP: sysstolic pressure; LVEDP: left ventricular end diastolic pressure; LVESP: left 
ventricular end systolic pressure; EDV: end diastolic volume; ESV: end systolic volume; MAP: mean arterial 
pressure; SV: stroke volume; EF: ejection fraction; HR: heart rate; CO: cardiac output; Emax: peak left ventricular 
contractility; SVR: systemic arterial resistance. Sympathetic activity and parasympathetic activity are in mean value 
(spikes/s). ESP for the model is hard to read thus assumed the same as MAP.  
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The different types of heart failure in section 4.2 can be reproduced very well by 
decreased Emax and/or increased Emin. It can also be seen from Figure 4.10 that, because of the 
control of the baroreflex, the heart rate and systemic vascular resistance increase to compensate 
the decrease in the cardiac output due to changes in heart contractility (or compliance) and keep 
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c. Combination of systolic dysfunction and diastolic dysfunction. 
Figure 4.10. Comparison of simulation results with baroreflex and without baroreflex. 
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The MAP of the case with baroreflex is higher than that of the case without baroreflex due to the increase 
in HR and SVR. 
 
4.4.2 Simulation result 2 (  = 35 ml, = 300 ml) oV TV
Repeat the simulations in subsection 4.4.1 with and  changed. The results are shown in 
Figure 4.11, Figure 4.12, Figure 4.13 and Table 4.6. The effect of changes in and  is shift to 
right of the P-V loops.  The changes in hemodynamics in the simulations with respect to that of 


































Figure 4.11. Systolic dysfunction P-V loops. ( = 240 ml) 0TV
P-V loops shift to the right because of increased Vo. 
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Figure 4.12. Diastolic dysfunction P-V loops. ( = 250 ml) 0TV



































Table 4.6. Simulation results for heart failure (2) 












of  (1) and (2) 
Clinical data 
from [67]
(23 patients ) 
DP(mmHg) 72 71 72 71 56.8 10.4 ±
SP(mmHg) 108 96 98 85 100.6 12.4 ±
LVEDP (mmHg) 7 8 17 17 No  
LVESP (mmHg) 89 84 87 78 No  
MAP (mmHg) 89 84 87 78 74.8 10.7 ±
EDV (ml) 121 165 121 122 No 
ESV (ml) 44 117 70 96 No  
SV (ml) 77 48 51 26 No 
EF (%) 63.6 28.7 42.3 21.2 No  
HR (bpm) 69 92 87 111 89.1 17.6 ±
CO (l/min) 5.3 4.4 4.4 2.9 3.54 0.48 ±
SVR 
(mmHg/ml/s) 
0.91 1.01 0.92 1.21 1.20 0.32 ±
Emax 
(mmHg/ml) 
2.7 1.2 2.8 1.4 No 
Emin (mmHg/ml) 0.06 0.06 0.2 0.2 No 
Sympatheteic 
activity 
2.77 2.84 2.80 2.95 No 
Parasympath 
activity 













of  (1) and (2) 
Clinical data 
from [67]
(23 patients ) 
DP (mmHg) 72 60 66 56 56.8 10.4 ±
SP (mmHg) 108 98 99 82 100.6 12.4 ±
LVEDP (mmHg) 7 8 18 18 No  
LVESP (mmHg) 89 80 84 70 No  
MAP (mmHg) 89 80 84 70 74.8 10.7 ±
EDV (ml) 121 176 128 135 No 
ESV (ml) 44 113 70 92 No  
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Table 4.6 (continued) 
SV (ml) 77 63 58 43 No 
EF (%) 63.6 35.6 45.2 32.1 No  
HR (bpm) 69 69 69 69 89.1 17.6 ±
CO (l/min) 5.3 4.3 4.0 3.0 3.54 0.48 ±
SVR 
(mmHg/ml/s) 
0.91 0.91 0.91 0.91 1.20 0.32 ±
Emax 
(mmHg/ml) 
2.7 1.2 2.7 1.4 No  
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c. Combination of systolic dysfunction and diastolic dysfunction. 
Figure 4.14. Comparison of simulation results with baroreflex and without baroreflex. 
The MAP of the case with baroreflex is higher than that of the case without baroreflex due to the increase 
in HR and SVR. 
 
Similar to that in subsection 4.4.1, because of the control of the baroreflex, the heart rate 
and systemic vascular resistance increase to compensate the decrease in the cardiac output due to 
changes in heart contractility (or compliance) and keep the blood pressure in acceptable range. 
4.4.3 Simulations results of specific clinical heart failure 
Some cases of failing heart P-V loops from [71] in Figure 4.15 are reproduced by changing 
parameters of the heart failure model with the baroreflex. In Figure 4.16, the hypertrophic heart 
failure is simulated by increased Emin=0.2 mmHg/ml (normal 0.06), decreased = -5 ml 
(normal 5) and = 145 ml. the steady total = 220 ml (normal 250). The dilated heart failure 
is simulated by decreased Emax=1.0 mmHg/ml (normal 2.7), increased = 100 ml (normal 5) 
and = 345 ml. the steady total = 400 ml (normal 250). Figure 4.17 shows the two cases of 
heart failure responses to reduction in preload. In this simulation of response to preload, the total 





Comparing the simulations results in Figure 4.16 and Figure 4.17 to that in Figure 4.15, it 
can be seen that both hypertrophic and dilated heart failure can be reproduced fairly well. With 
reduction in preload, MAP decreases and heart rate increases in the simulation. The simulation 
result is consistent with the clinical experiment. 
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a. Hypertrophic cardiomyopathy. The right most is the P-V loop of baseline. 
 
 
b. Dilated cardiomyopathy. The right most is the P-V loop of baseline. 
 
Figure 4.15. P-V loops of failing heart responses to changes in preload (adopted from [71]). 
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a. Reproduced P-V loop (solid line) of hypertrophic cardiomyopathy ( = -5 ml, = 220 ml, oV TV
Emin = 0.2 mmHg/ml ). Broken line is the normal one. 




























b. Reproduced P-V loop (solid line) of dilated cardiomyopathy ( = 100 ml, = 400 ml, oV TV
Emax = 1.0 mmHg/ml). Broken line is the normal one. 
Figure 4.16. Model reproduced clinical baseline failing heart P-V loops. 
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a. Hypertrophic cardiomyopathy response to change in preload (Total blood volume changed from 220 to 
200 ml). 

























b. Dilated cardiomyopathy response to change in preload (Total blood volume changed from 400 to 360 
ml). 
 
Figure 4.17. Simulation results of failing heart response to changes in preload. 
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In this section, some cases of heart failure and clinical experiment are simulated by 
combinations of decreased Emax and/or increased Emin,  and . It can also be seen from the 
simulation results that, comparing to the corresponding case without baroreflex, because of the 
control of the baroreflex, the heart rate and systemic vascular resistance increase to compensate 
the decrease in the cardiac output due to changes in heart contractility (or compliance) and keep 
the blood pressure in acceptable range.  
oV TV
4.5 RESPONSES OF HEART FAILURE TO EXERCISE 
The responses to exercise for the two types of heart failure in subsection 4.4.3 are simulated. 
Similar to that of section 3.5, in the simulation of exercise, the set point change is induced by 
adding offset to efferent pathways (forced changes in  and ) linearly in 5 
seconds. In Figure 6.18, the offsets start changing progressively from 10s. At 15 s, the exercise 
begins, 
_offset es _offset ev
13R  starts decreasing due to local vasodilatation in active muscle (forced change linearly 
in 10 seconds), but heart rate increases continually until it achieves a new steady value. Because 
the ability of adjustment of end organs may be damaged for a patient with heart failure, the value 
of muscle resistance in exercise is set higher than that in the case of simulation of healthy people. 
This is applied to both hypertrophic and dilated heart failure. Multiple levels exercise responses 
are examined and compared to the data collected from heart failure patients exercise experiment 
in [54]. 
4.5.1 Hypertrophic heart failure  
Multiple exercise levels are simulated by using the experimental data from [54] as reference to 
tweak the combinations of nervous offsets and forced change in 13R  (muscle resistance). The 
complex of changes from rest to a certain level of exercise is shown in Figure 4.18 and P-V  
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Figure 4.18. Response to exercise for hypertrophic heart failure. 
MAP in mmHg, AF (aortic flow) in L/min, HR in bpm, SVR in mmHg/ml/s, (MAP, CO, SVR) changes 
from (81, 3.6, 1.08) to (97, 6.3, 0.74) during exercise. 



























Figure 4.19. P-V loops of rest (dotted line) and exercise (solid line). 
The loop for exercise expands to the right. The end diastolic volume and end systolic pressure increase. 
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loops in Figure 4.19. As shown in Figure 4.19, the changes in P-V loops from rest to exercise 
include expansion to the right and increase in end diastolic volume and increase in end systolic 
pressure. The hemodynamic changes are listed in Table 4.7. The hemodynamic changes in 
percentage from rest to exercise (ratio of exercise to rest) are shown in Figure 4.20.  
 
Table 4.7. Hypertrophic heart failure response to exercise 
Exercise level  0 1 2 3 








MAP (mmHg) 92 100 110 118 
HR (bpm) 86± 17 98 114 134 
SV (ml) 49± 15 60 60 58 
CO (L/min) 4.0± 1.2 6.2 7.0 8.2 
SVR (mmHg/ml/s) 1.41 1.05 0.87 0.87 
SVR/LVR 13± 5 32 48 52 
Simulation results 0 1 2 3 
(O1,O2) Rest (0.16,0.1) (0.26,0.4) (0.31,0.6) 
MAP (mmHg) 81 87 93 97 
HR (bpm) 98 112 129 143 
SV (ml) 37 44 44 44 
CO (L/min) 3.6 4.9 5.7 6.3 
SVR (mmHg/ml/s) 1.08 0.84 0.78 0.74 
R13 (mmHg/ml/s) 8.5 2.1 1.6 1.4 
SVR/R13 (%) 12.8 40.0 48.2 52.5 
kpm: kilopond meters /min. 
O1: offset in sympathetic activity caused by central command. 



































Exercise level 3 
Figure 4.20. Hemodynamic changes from rest to exercice. 
MAP, CO, and HR increase, SVR decreases with increasing exercise intensity. 
 
The experiment data from [54] and simulation results for multiple exercise levels are 
illustrated in Figure 4.21. With increasing exercise intensity, the tendency of changes in 
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hemodynamics is similar to that of healthy people but with less amounts and intolerance to 
higher exercise level (the heart rate is relatively high compared to the corresponding possible 
maximum). The results are consistent with the data in [54]. 




















































Figure 4.21. Changes in hemodynamics for multiple exercise levels. 
Diamond: experiment data from [54]; Square: simulation results. 
4.5.2 Dilated heart failure  
The complex of changes of dilated heart failure response to exercise is shown in Figure 4.22 and 
P-V loops in Figure 4.23. As shown in Figure 4.23, the changes in P-V loops from rest to 
exercise include shift to the right and increase in end diastolic volume and increase in end 
systolic pressure. The hemodynamic changes are listed in Table 4.8. The hemodynamic changes 
in percentage from rest to exercise are shown in Figure 4.24. The experiment data from [54] and 
simulation results for multiple exercise levels are illustrated in Figure 4.25. With increasing 
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exercise intensity, the changes in hemodynamics are similar to that of healthy people. The results 
are consistent with the data in [54]. 


































Figure 4.22. Response to exercise for dilated heart failure. 
MAP in mmHg, AF (aortic flow) in L/min, HR in bpm, SVR in mmHg/ml/s, (MAP, CO, SVR) changes 
from (86, 4.5, 0.98) to (88, 5.9, 0.75) during exercise. 





























Figure 4.23. P-V loops of rest (dotted line) and exercise (solid line). 
The loop for exercise shifts to the right. The end diastolic volume and end systolic volume increase. 
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Table 4.8. Dilated heart failure response to exercise 









MAP (mmHg) 92 100 110 118 
HR (bpm) 86± 17 98 114 134 
SV (ml) 49± 15 60 60 58 
CO (L/min) 4.0± 1.2 6.2 7.0 8.2 
SVR (mmHg/ml/s) 1.41 1.05 0.87 0.87 
SVR/LVR 13± 5 32 48 52 
Simulation results 0 1 2 3 
(O1,O2) Rest (0.17,0.02) (0.26,0.2) (0.31,0.6) 
MAP (mmHg) 86 93 97 101 
HR (bpm) 89 104 118 132 
SV (ml) 52 56 55 52 
CO (L/min) 4.6 5.9 6.5 7.0 
SVR (mmHg/ml/s) 0.96 0.81 0.76 0.74 
R13 (mmHg/ml/s) 7.4 2.1 1.6 1.4 


































Exercise level 3 
Figure 4.24. Hemodynamic changes from rest to exercice. 
MAP, CO, and HR increase, SVR decreases with increasing exercise intensity. 



















































Figure 4.25. Changes in hemodynamics for multiple exercise levels. 
Diamond: experiment data from [54]; Square: simulation results. 
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For both cases of heart failure, from rest to exercise, the tendencies of changes in MAP, 
CO, and SVR are similar to that of healthy people but the amounts of changes are less than that 
of healthy people due to physiological changes in the patients with heart failure. The increased 
HR during exercise (relatively low level for healthy people) nearly achieves the maximal 
possible value for heart failure patients (exercise intolerance). 
4.6 CONCLUSION 
 
Based on the healthy cardiovascular model, some parameters of the cardiovascular system and 
the baroreflex are changed to simulate heart failure. Because of the control of the baroreflex, the 
heart rate and the systemic vascular resistance increase to compensate the decrease in the cardiac 
output due to changes in heart contractility and/or compliance and keep the blood pressure in 
acceptable range. Some cases of clinical heart failure can be simulated by changing parameters 
of the model (Emax, Emin, Vo, total blood volume). The responses to multiple levels of exercise 
for two types of heart failure are simulated. From rest to exercise, the tendencies of changes in 
MAP, CO, HR, and SVR are similar to that of healthy people but the amounts of changes are less 
than that of healthy people due to pathophysiological changes in the patients with heart failure. 
As shown in the simulation results, without the baroreflex, the model will not be able to simulate 
the changes in heart rate and the systemic vascular resistance and the resulting compensation for 





5.0  THE COMBINED MODEL OF PUMP AND FAILING HEART  
In this chapter, a pump model is introduced first in section 5.1. Then the pump model is coupled 
to the failing heart to simulate the interaction between the pump and the cardiovascular system in 
section 5.2. In section 5.3, the behavior of the coupled model of the pump, the heart and the 
baroreflex is examined.   
5.1 THE PUMP MODEL 
The rotary pump is a mechanical device driven by a motor. The rotation of the motor and the 
impellor of the pump force the blood to flow from the inlet of the pump to the outlet of the pump 
and generate a pressure rise across the pump. The electrical power is converted to mechanical 
power during this process. Therefore, the pump works under electrical and mechanical and/or 





  v(t) 
DC motor:
bK ( )tω J
B Km fT hT  
 
 
Figure 5.1. DC motor circuit 
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The electrical part of the DC motor equation (using Kirchhoff’s voltage law) 
satisfies:  
( )( ) ( ) ( )b
di tt L Ri t K t
dt
υ ω= + +      (5.1) 
Where  
bK  is the EMF constant 
( )tω  is rotating speed 
The DC motor’s mechanical part (using Newton’s law) satisfies:   
( ) ( ) ( )i m f
d tJ T K i t B t T
dt h
Tω ω= = − − −∑     (5.2) 
Where  
J  is the inertia load of the rotor 
( )i t  is current 
B is a linear constant approximation for mechanical friction 
Km, the armature constant, is related to physical properties of the motor, such as 
magnetic field strength, the number of turns of wire around the conductor coil 
fT is a constant friction torque 
hT  is the load torque exerted on the pump (coming from the hemodynamic, 
related to heart) 
The load torque is derived from the shaft work performed by the motor upon the impeller, 
and is related to pump efficiency through:  
 hT HQη ω =        (5.3) 
Where  
H  is pressure difference between the outlet and the inlet of the pump, 
Q  is flow rate. 
The hydraulic efficiency η is a function of speed and flow rate: 
( , , )H Qη η= ω       (5.4) 
Typically, 
)( sNηη =        (5.5) 





NQN s =        (5.6) 
In fact this “specific speed”, a non-dimensional number (normalized by the size and 
nominal running speed of the pump), is used to describe the characteristic of the pump in the 
design stage. In other words, the design objective is to achieve the maximal efficiency at a 
specific speed (once the pump is made, operating speed is the only variable for determining the 
efficiency). If the pump is not running at nominal speed, the efficiency will drop a little bit. 
These ideal equations are derived from electrical and mechanical principles. Note that 
there are two possibilities for a certain patient status in LVAD application:  
1. If the left ventricle has no contractility (the left ventricle in complete failure),  becomes 
a constant, the speed and current of LVAD will become constants eventually.  
hT
2. If the left ventricle has contractility (the left ventricle still operating),  fluctuates 
dramatically, speed, current will be under the influence of this term. 
hT
For the second case,  will oscillate, the difficulty of solving for the desired variables 
arises. It should be pointed out that when combining these two equations an extra part of energy 
(or power) should be considered: if the ventricle still has contractility, the cardiac output is the 
result of the sum of blood pump power and left ventricular contraction power.  
hT
These basic equations for the pump are the basis for all VAD simulations and variable 
estimations. Because of power loss, parameters uncertainty and difficulties of solving these 
equations for  and Q directly, some researches turn to estimating  and Q with functions of 
current and speed. The objective of the estimation is to achieve approximate instantaneous 
waveforms of  andQ  in a certain speed range. 
H H
H
The experimental data in Figure 5.2 illustrates a family of static characteristic curves for 
a typical rotary pump (Nimbus) describing the relationship between the pump flow and the 
pressure difference across the pump with various rotational speeds [72]. 
An empirical pump model was developed in [4]. The model describes the relationship of 
the pump rotational speed, the pump flow and pressure difference across the pump. It is an 
empirical model with parameters determined from experiments.  
2
0 1 2O i
dQH P P B Q B B
dt
ω= − = + +      (5.7) 
Where 
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0B , 1B  and 2B are parameters determined from experiments 
ω  is pump speed 
H is pressure difference across the pump (pump head) 
Here the pump speed is supposed to be adjusted directly (in fact the speed need to be solved in 
the pump dynamic equations).  
 
 
Figure 5.2. Rotary pump characteristic curves [72]
5.2 THE COUPLED MODEL OF THE PUMP AND THE FAILING HEART 
In a typical pump implantation, the pump is connected between the left ventricle and the aorta. 
The flow through the pump and cannula is in parallel with the aortic flow. When the pump and 
cannula connect to the cardiovascular system model, the pump flow is added to the combined 
model as another state variable. The combined model is shown in Figure 5.3. In this model, the 
addition of circuit to the network, four passive parameters LO, RO, L1, and R5, is related to the 










>⎧= ⎨− +⎩     (5.8) 
where Pth = 1 mmHg is a threshold.  
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Table 5.1 lists the state variables and Table 5.2 lists the model parameters. For this 
combined model, the SVR, HR and Emax are under the control of the baroreflex thus it is a time 
varying system. The resulting model is also a forced system with the pump speed as the primary 
control variable. 















Figure 5.3. The coupled model of pump and failing heart 
 
Table 5.1. State variables 
Variables Physiological meaning (units) 
xc1 Left ventricular volume (ml) 
xc2 Left atrial pressure (mmHg) 
xc3 Arterial pressure (mmHg) 
xc4 Total flow (ml/s) 








Table 5.2. Model parameters 
Parameters Value Physiological Meaning Units 
Resistances    
R1(t) Time varying Systemic Resistance  
R2 0.005 Mitral valve (open)  
 ∞ Mitral valve (close)  
R3 0.001 Aortic valve (open) mmHg.s/ml 
 ∞ Aortic valve (closed)  
R4 0.0398 Characteristic resistance  
R5 0.0677 Cannulae inlet resistance  
RO 0.0677 Cannulae outlet resistance  
R6 Pressure dependent   
Compliances    
C1(t) Time 
varying 
Left ventricular compliance  
C2 4.4 Left atrial compliance ml/mmHg 
C3 1.33 Systemic compliance  
Inertances    
L 0.0005 Inertance of blood in Aorta  
L1 0.0127 Cannulae inlet inertance mmHg.s2/ml
LO 0.0127 Cannulae inlet inertance  
Valves    
D1  Aortic valve  
D2  Mitral valve  
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Table 5.2. (continued) 
Pump     
B0 -0.1707   
B1 -0.02177   
B2 0.0000903   
Note that R1(t)  and C1(t) are under the control of the baroreflex, thus are time varying. 
The state equations of the coupled model can be written as 
( ) ( )dx A t x bu t
dt
= +      (5.9) 
where  is the control variable and A(t) can be either a (4 x 4) or a (5 x 5) time 
varying matrix, depending on the modes of D
2( ) ( )u t tω=
1 and D2. The dimension of the vector b, changes 
accordingly, i.e., it can be (4 x 1) or (5 x 1). The following 3 phases will occur in a cardiac cycle, 
over four different time intervals. 
1) Isovolumic phase: In this phase, the aortic and mitral valves are closed. Moreover, total flow 
is equal to pump flow, i.e., xc4(t) = xc5(t). In this case, we have 
1 2 1 2
1 3 1 3 3
4
0 0 0 1
1 10 0
( ) 1 1 10
( ) 10
' '
R C R C
A t
R C R C C
E t R R
L L L L L L
−
'
⎡ ⎤⎢ ⎥⎢ ⎥−⎢ ⎥⎢ ⎥= ⎢ ⎥−⎢ ⎥⎢ ⎥+⎢ ⎥− −⎢ ⎥+ + +⎣ ⎦
  (5.10) 
and  
b = [0  0  0  -b2/(L' + L)]T     (5.11) 
where L’ = L1 + L0 + b1 and R = R5 + R0 + R6 + b0. 
2) Ejection phase: In this phase, the aortic valve is open, and the mitral valve is closed. In this 
case, two flows go into the circulatory system, from the aorta and from the pump.  
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1 2 1 2
1 3 1 3 3
3 4 3
3 3
0 0 0 1 0
1 10 0
1 1 10 0( )
( ) 1 ( )0
0 0 0
R C R C
A t R C R C C






−⎡ ⎤⎢ ⎥⎢ ⎥−⎢ ⎥⎢ ⎥⎢ ⎥−= ⎢ ⎥⎢ ⎥+⎢ ⎥− −⎢ ⎥⎢ ⎥−−⎢ ⎥⎢ ⎥⎣ ⎦
  (5.12) 
and  
b = [0  0  0  0  -b2/L]T     (5.13) 
3) Filling phase: In this phase of the cardiac cycle, the mitral valve is open, and the aortic valve 
is closed, blood from the left atrium goes into the left ventricle. This again implies xc4(t) = xc5(t). 
For this phase, 
2 2
1 2
2 2 1 2 2 1 2
1 3 1 3 3
4
( ) 1 0 1
( ) ( ) 1 0
( )
1 1 10




E t R R
R C R R C R CA t
R C R C C
E t R R
L L L L L L
⎡ ⎤− −⎢ ⎥⎢ ⎥+⎢ ⎥−⎢ ⎥= ⎢ ⎥⎢ ⎥−⎢ ⎥⎢ ⎥− − +⎢ ⎥⎢ ⎥+ +⎣ ⎦'+
   (5.14) 
and  
b = [0  0  0  -b2/(L' + L)]T    (5.15) 
The case with both valves open does not occur for a normal heart and thus is not included 
in this model. For a sequence of these phases in a normal cardiac cycle, for example, filling-
contraction-ejection-relaxation, the end states of the last phase are initial conditions for the next 
phase. The block diagram Figure 5.4 shows the coupling between the failing heart, the pump and 
the baroreflex. The arterial pressure is the input for the baroreflex. The contractility (Emax) of 
the left ventricle is fixed at a low value to simulate the heart failure. The SVR, HR and VT (total 
blood volume) are under the control of the baroreflex. Specifically, the SVR and VT vary 
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instantaneously; the HR (or cardiac cycle) varies cycle by cycle, in other words, the HR remains 
constant in a cardiac cycle. 
 
Baroreflex 
Failing heart + 
Pump 
Arterial 
Pressure SVR, HR,VT      
 
 
Figure 5.4. Pump augmented failing heart with baroreflex 
5.3 CHANGES IN HEMODYNAMICS WITH PUMP IMPLANTED 
Clearly, an implanted pump will have impact on the native cardiovascular system. Specifically, 
the hemodynamic variables will vary corresponding to the changes caused by the baroreflex and 
the pump speed (rotary pumps). Such changes will be simulated and compared to the clinical 
experiments in the literature. 
Figure 5.5 shows changes in P-V loops when the pump speed (or rate) increases for the 
clinical experiment in [74] and simulation. With increasing pump speed, the P-V loops shrink 
towards the left bottom corner of the coordinate in both the clinical experiment and simulation. 





a. P-V loops for pump on-off test in a clinical experiment (adopted from [74]) 
 


























w = 10600 
 w = 9600
w = 8600 
 
 
b. Simulation with increasing pump speed 
 
Figure 5.5. P-V loops changes with changing pump speed 
With increasing pump speed, the P-V loops shrink towards the left bottom corner of the coordinate.  
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8,100 86 87 4.3 0.98 
8,600 86 84 4.5 0.94 
9,100 88 79 5.1 0.87 
9,600 89 75 5.7 0.81 
10,100 91 72 6.3 0.76 
10,600 94 69 7.0 0.71 
CO: total blood flow (pump flow + aortic flow). 
 
It can be seen that with increase in pump speed, the cardiac output and blood pressure 
increase, heart rate and systemic vascular resistance decrease. These hemodynamic changes with 
increase in pump speed can be verified by the clinical data. There are some experiments on 
patients with pulsatile LVADs implanted in [75]. The stroke volume for this implanted pulsatile 
pump is 80 ml/stroke. For the experiment of partial pump support, the pumps were running at a 
lower fixed rate and lower pump flow (far below the blood flow requirement of the body). At 
first, the pump was in full support for the heart. Then the pump was turned to partial support. 
During this experiment, mean arterial blood pressure decreased, heart rate increased, and cardiac 
output fell.  
For the simulations of the full and partial pump support, the pump speed is adjusted to 
match the cardiac output in the clinical experiment accordingly. Simulation results with the 
baroreflex decoupled are listed for comparison. For the case with baroreflex, the heart rate and 
systemic vascular resistance are under the control of the baroreflex. For the case without 
baroreflex, the heart rate and systemic vascular resistance are the same for the full and partial 
pump support. Table 5.4 shows the experiment results (18 patients) and simulation results. 





Table 5.4. Full and partial pump support  






LVAD operating rate 
(cycles/min) 
66± 11 28± 9 
MAP (mmHg) 91± 8 71± 12 
HR (bpm) 94± 12 106± 17 
CO (L/min) 5.3± 1.0 4.2± 1.2 






LVAD operating rate (rpm) 9,300 8,100 
MAP (mmHg) 88 86 
HR (bpm) 77 87 
CO (L/min) 5.4 4.3 
SVR (mmHg/ml/s) 0.85 0.98 






LVAD operating rate (rpm) 9,300 8,100 
MAP (mmHg) 88 78 
HR (bpm) 77 77 
CO (L/min) 5.4 4.5 



















Figure 5.6. Changes in hemodynamics (ratio of partial to full) 
Experiment results from [75]. 
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The changes in HR and CO match pretty well but the change in MAP does not. It is 
apparent that the SVR does not change in the experimental data (MAP and CO have nearly the 
same percent change).  
5.4 CONCLUSION  
The pump model is coupled to the failing heart model with built in baroreflex. The simulation 
results have the same trends for the P-V loops and hemodynamic changes as that of the clinical 
experiment for the full and partial pump support. With increasing pump speed, the P-V loops 
shrink to the left bottom corner in the coordinate, mean arterial pressure increased, heart rate 
decreased, and cardiac output increased.  
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6.0  PUMP CONTROL BASED ON HEART RATE AND SYSTEMIC VASCULAR 
RESISTANCE 
For a normal heart, the cardiac output (CO) is determined by two factors: stroke volume (SV) 
and heart rate (HR). From rest to exercise, both stroke volume and heart rate increase, thus the 
resulting greater CO can meet the increased blood flow requirement. More generally, the 
physiological status of the patient may demonstrate a wide range of variation, due to exercise 
intensity and emotional changes. Thus a controller that can detect and adapt to the real time 
physiological changes of the body is important for the LVAD application. 
The baroreflex function is preserved fairly well in the patients with heart failure even 
though some end organ functions are damaged or attenuated. The increase in stroke volume for 
healthy people during exercise is the result of a complex of physiological process: increasing 
blood return, increasing heart contractility and decreasing systemic vascular resistance. The 
increased heart rate and decreased systemic vascular resistance are observed during exercise in 
the patients with heart failure. Incorporating this information can make the LVAD controller 
responsive to the change in physiological state of the body. With the baroreflex model coupled to 
the cardiovascular system model in the simulation, the controller can use this information to 
estimate the blood flow requirement of the body and drive the pump to meet this estimated 
requirement. The feasibility of this controller will be investigated in this chapter. First, the pump 
operation will be illustrated in section 6.1 by using a superimposed pump characteristic curves 
and a simplified physiological constraint on the H-Q plane. Second, the pump controller based 
on HR and SVR will be described in section 6.2. The simulation results will be compared to that 
of constant speed method, constant pump head method and heart rate related pump speed control 
method in section 6.3. Third, the performance of this proposed method with respect to changes in 
parameters and tolerance to noise will be examined in section 6.4. 
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6.1 PUMP OPERATION 
In general, the rotary pump can be simplified as a model in which the pressure rise across the 
pump is a function of pump speed and pump flow. The pump model 
( , )H f Q ω=       (6.1) 
where H is the pressure rise across the pump, Q is pump flow, and ω is pump speed.  
For a certain physiological state of the body, a specific pump speed needs to be set for the 
implanted pump. Figure 6.1 illustrates a family of the static pump characteristic curves and an 
operating point (Ho, Qo, ωo). When the pump is coupled to a failing cardiovascular system, (Ho, 
Qo) is constrained by the coupled cardiovascular system and the pump, and also needs to meet 
the physiological requirement of the body. In the illustration, the physiological state is simplified 
by a certain SVR; a prescribed Qo will result in a certain Ho and ωo. The corresponding pump 
speed ω0 is the desired operating speed for this prescribed Qo. Similarly, a prescribed Ho will 
result in a certain Qo and ωo. The corresponding pump speed ωo is the desired operating speed for 











Figure 6.1. Static pump characteristic curves and operating point. 
Superimposed pump characteristic curves and physiological state of the body. H is the pump head and Q is 
the pump flow, ω is the pump speed. 
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If both H and Q are prescribed and are not coincident, as shown in Figure 6.2, no single 









Figure 6.2. Same SVR and different operating points. 
 
The operating point may move in the H-Q plane for different physiological states. From 
rest to exercise, SVR decreases, both H and Q increase, the operating point moves right upward, 












Figure 6.3. Change in operating points from rest (1) to exercise (2). 
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6.2 PROPOSED PUMP CONTROL BASED ON HR AND SVR 
As mentioned before, the increased HR and decreased SVR are observed from rest to exercise 
for patients with heart failure. Thus it is reasonable to assume that HR and SVR are still under 
the control of the baroreflex for the patients with heart failure. We further assume that HR and 
SVR of the patient can be measured or estimated with a pump implanted [10]. The pump speed is 
chosen to match the physiological state of the body, which is estimated by using the HR and 
SVR. Figure 6.4 shows the closed-loop block diagram. 
Heart + pump Hemodynamic 
Variables 
Estimations of 
HR and SVR 
Speed update 
Pump speed  
 
Figure 6.4. Block diagram for the closed-loop control based on HR and SVR. 
 
Since the left ventricle contractility for severe heart failure is decreased significantly, it is 
reasonable to assume that the aortic valve is always closed when the pump takes the role of the 
left ventricle pumping the blood out of the chamber. Thus, the combined model of the pump and 
the cardiovascular system in Figure 5.2 can be simplified as Figure 6.5. The aortic valve is open-
circuited and is taken out in Figure 6.5.  
This proposed controller will be manipulated by using mean hemodynamic variables. 
Thus the circuit in Figure 6.5 can be further reduced to a circuit in mean sense by eliminating the 
constant capacitors and inductors. The reduced circuit diagram in mean sense is shown in Figure 




























Figure 6.6. Reduced circuit diagram in mean sense. 
 
For a healthy human, the cardiac output (CO) is the product of the stroke volume (SV) 
and the heart rate (HR), 
CO HR SV= ∗      (6.2) 
When exercise starts, both HR and SV increase thus CO increases. 
 101 
With the pump coupled to a failing heart, if ignore the small resistances in the circuit, the 
pressure rise across the pump H is the difference between the aortic pressure (AOP) and the left 
ventricular pressure (LVP), 
H AOP LVP= −      (6.3) 
To mimic the healthy heart response to exercise, we want the pump to operate in a similar 
fashion to that of the healthy heart. In other words, we want pump to generate estimated 
reference amounts of H and CO: H0 and CO0. If the failing left ventricle does not have enough 
contractility to open the aortic valve, thus CO is equal to the pump flow.  In this case, the 
estimated references pump flow, arterial pressure and pump head 
0 rCO HR SV= ∗      (6.4) 
0 0AOP CO SVR= ∗      (6.5) 
0 0 rH AOP LVP= −      (6.6) 
where and  are preset values. Especially,  has a different value for rest and 
exercise.  
rSV rLVP rSV
The block diagram of this control scheme is shown in Figure 6.7. In this diagram, the 
variables HR, H and CO are averaged value over a cardiac cycle. With these estimated reference 
values for the pump head and flow, the errors between the real ones and these reference values 
will be used to change the pump speed towards the desired value. 
To mimic the change in stroke volume for different states of a healthy person (rest and 
exercise), the stroke volume is set as a function of the heart rate (to mimic the increase in stroke 






≤⎧= ⎨ >⎩     (6.7) 
The instantaneous left ventricular pressure depends on the volume and the contractility of 
the left ventricle, both of which are time varying. Here a constant mean value is used in the 
simulation, 
=50 mmHg rLVP      (6.8) 
Considering the arterial pressure can not increase or decrease beyond some reasonable range, the 













− ≤⎧= ⎨ − >⎩
    (6.9) 
Given (6.8), this implies that H0 is saturated at 110 mmHg. 
In the block diagram, the pump speed is updated with: 
1k kω ω+ ω= +?       (6.10) 
01 ( ) 2 ( )K H H K CO CO0ω = ∗ − + ∗ −?    (6.11) 
where K1 and K2 are constants. The values for them are chosen to be the possible maximum not 
to cause overshoot in the transition from rest to exercise. 
To simulate the failing heart the contractility index Emax is set equal to 0.7  mmHg/ml 
(normal value is 2.7 mmHg/ml). The exercise in the simulation is induced by adding offsets to 
efferent nervous signals and forced change in active muscle resistance. Figure 6.8 shows the 
response of the controller to a certain level of exercise. Figure 6.9 shows the errors between the 
estimated reference values and actual values for H and Q in a certain simulation run. Figure 6.10 
shows the trajectory of the operating point in the pump H-Q plane. Figure 6.11 shows the LVP 
























Δω = Δω1 + Δω2 
0 rCO HR SV= ∗
0 0AOP CO SVR= ∗  
0 0 rH AOP LVP= −  
Average  
Variables 
in a  
Cardiac 
Cycle   
 
Figure 6.7. Block diagram for the controller based on the HR and SVR. 
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Time (seconds)  
 
a. Forced changes to induce the exercise 
 






























Time (seconds)  
 
b. Hemodynamic variables 
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c. Forced changes for rest-exercise-rest 
 

































d. Hemodynamic variables for rest-exercise-rest 
 
Figure 6.8. Controller responses to exercise level 2.  
At 15s, exercise starts. K1=0.004, K2=0.004, . AOP: aortic pressure in mmHg; Q: pump 
flow in L/min; HR: heart rate in bpm; SVR: systemic vascular resistance in mmHg/ml/s; Speed: pump speed in 
krpm. Operating point for exercise: H = 98mmHg, CO = 9.3 L/min, Speed = 12.4 krpm. 
=50 mmHg rLVP
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Time (seconds)  
 
Figure 6.9. Control errors for H and Q from rest to exercise level 2. 
Broken lines are estimated reference values and solid lines are actual values. K1=0.004, K2=0.004, 
.  The portion from 17s to 25s for estimated reference H=50 mmHg rLVP 0 is saturated. 






















Figure 6.10. Operating point trajectory from rest to exercise 
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Figure 6.11. LVP and LVPr 




















Figure 6.12. AOP and LVP 
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The simulation results are consistent with the analysis in Figure 6.3.  From rest to 
exercise, (1) the blood pressure and cardiac output increased; (2) the operating point in the H-Q 
plane moved right upward; (3) the pump speed increased. It can be seen from the results that 
there are steady state errors between the estimated reference values and the real values. This is 
caused by the two not coincident prescribed references values: one for H and the other one for 
CO. As illustrated in Figure 6.13, for a certain physiological state (simplified by SVR), the two 
corresponding estimated operating points are different in the H-Q plane. The final actual 
operating point is located in between these two operating points. The steady errors are the 
difference between the actual H and Q and the estimated reference H0 and Q0. This can be further 
clarified by Figure 6.14 and Figure 6.15. In these two cases, only one of the H and CO branches 
is applied in the closed loop control. For each of the two special cases, the steady error for the 






Figure 6.13. Illustration of the operating point and steady errors. 
The star is the actual operating point. Solid lines are actual operating values. Broken lines are estimated 








































b. Operating point  




































K1 = 0 
 
b. Operating point  
Figure 6.15. K1 = 0 (only CO branch is applied) 
 
Also, the estimated operating points for H and CO branches may switch their relative 
positions.  In Figure 6.16, for exercise level 1, the operating position relative to H0 and CO0 is 
similar to that of exercise level 2; for exercise level 3, H0 and CO0  switch their positions, as 
shown in Figure 6.17. Table 6.1 lists hemodynamic variables for multiple levels of exercise. 
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Figure 6.18 illustrates the results comparing to the experimental heart failure data in the literature 
[54].  
 





















Time (seconds)  
a. Exercise level 1 






















Time (seconds)  
b. Exercise level 3 









Figure 6.17. Operating point for exercise level 3 
 





















































Figure 6.18. Multiple levels of exercise 
Diamond: simulation with controller; square: experimental heart failure data from [54]; triangle: heart 
failure simulation without pump. SVR/R13: ratio of systemic resistance to active muscle resistance. 
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Table 6.1.  Multiple levels of exercise 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9,567 11,000 12,347 13,267 
MAP (mmHg) 87 104 125 140 
HR (bpm) 78 89 109 136 
CO (L/min) 5.3 7.3 9.1 10.6 
SVR (mmHg/ml/s) 0.85 0.75 0.73 0.71 
 
6.3 COMPARISON OF THE PROPOSED PUMP CONTROL WITH OTHER 
METHODS 
It is desirable to compare the response to exercise of this control method to other methods. The 
methods considered here include the constant speed and constant pump head method, and the 
method of pump speed as a linear function of the heart rate. For comparison, the starting points 
are the same for all these methods, and different levels of exercise will be used to test the 
responses of these different methods.  
6.3.1 Constant speed method 
This method is actually used in real life. In the pump characteristic H-Q plane, the operating 
point will move along a certain pump speed curve. The response of this method to exercise level 
2 is shown in Figure 6.19. The simulation results for different levels of exercise are listed in 
Table 6.2. The pump speed is chosen as the same as that of the controller based on HR and SVR 
at rest. It can be seen that the MAP and CO increase in spite of the lack of left ventricular 
contractility; these increases are results of other baroreflex controlled compensation such as 
increased HR and total blood volume. 
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 Table 6.2. Simulation results for constant speed 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9567 9567 9567 9567 
MAP (mmHg) 87 92 97 100 
HR (bpm) 78 99 119 147 
CO (L/min) 5.3 6.1 6.3 7.1 
SVR (mmHg/ml/s) 0.85 0.80 0.76 0.73 
 


































Figure 6.19. Constant speed method response to exercise level 2. At 15s, exercise starts. 
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6.3.2 Constant pressure head method 
By keeping the pump head constant, this method can incorporate the change in SVR 
automatically [31]. The operating will move to the right horizontally in the pump H-Q plane. In 
the simulation, only the H branch is used and K1 = 0.008. The response of this method to 
exercise level 2 is shown in Figure 6.20. The simulation results of different levels of exercise are 
listed in Table 6.3. The pump pressure head is chosen to match the head at rest for the controller 
based on HR and SVR (H0 = 60 mmHg). The simulation results show that there are some 
increases in MAP and CO. 
 
































Figure 6.20. Constant pump head method response to exercise level 2. At 15s, exercise starts. 
 
Table 6.3. Simulation results for constant pump head 
Exercise level  0 1 2 3 









Table 6.3. Simulation results for constant pump speed (continued) 
Pump Speed (rpm) 9567 9812 9995 10164 
MAP (mmHg) 87 94 100 105 
HR (bpm) 78 96 116 142 
CO (L/min) 5.3 6.2 6.9 7.8 
SVR (mmHg/ml/s) 0.85 0.79 0.75 0.72 
 
6.3.3 Pump speed as a linear function of heart rate  
A control method is reported in  using heart rate as the control input. In the animal 
experiment, the controller 
[42]
adjusted the pump speed in response to increasing or decreasing heart 
rate in a linear relationship. To examine the performance of this control method, in the 
simulation, 
0 (k HR HR0 )ω ω= + ∗ −     (6.12) 
where ω0 , k, HR0 are constants. The values of them are chosen to match the cases for rest and 
exercise level 3. ω0 = 9568 rpm, k = 63 rpm/bpm, HR0 = 78 bpm. The response of this method to 
exercise level 2 is shown in Figure 6.21. The simulation results of different levels of exercise are 
listed in Table 6.4.  
 
Table 6.4. Simulation results for heart rate related pump speed method 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9542 10439 11590 13243 
MAP (mmHg) 87 99 115 140 
HR (bpm) 78 92 110 136 
CO (L/min) 5.3 6.7 8.4 10.4 
SVR (mmHg/ml/s) 0.85 0.77 0.73 0.71 
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Figure 6.21. Heart rate related pump speed method response to exercise level 2. 
 
Figure 6.22 compares the responses of the different methods to the same set of exercise 
simulations (the simulation results in Table 6.2 through 6.4). The experimental heart failure 
exercise data from [54] is also plotted for comparison (Table 4.8). Interestingly, the increase in 
pump flow for the constant speed method in the simulation is consistent with the animal 
experiment results in [76]. It can be seen that the pump speed, blood pressure and pump flow 
generated by the proposed controller is higher than that of the constant speed, constant pump 
head methods and the heart rate related pump speed method. Therefore the proposed control 
method can provide better support for the exercise. There is no suction for all the simulations. 
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Figure 6.22. Response to the exercise for different control methods 
Diamond: control based on HR and SVR; Triangle: constant pump head; Square: constant pump speed; 
Star: pump speed as a linear function of heart rate; Circle: experimental heart failure data ([54] without pump). 
 
6.4 PERFORMANCES OF THE PROPOSED CONTROLLER 
The factors that may affect the performance of the controller include the following: 
• K1 and K2 
• LVPr  
• SVr 
• Noise  
These factors will be examined one by one in this section. 
The simulation for a certain exercise level will be used to test the controller. Figure 6.23 
shows the simulation from rest to exercise level 2 without noise at K1 = 0.004, K2 = 0.004, 
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LVPr = 50 mmHg. Operating point: H = 98mmHg, CO = 9.3 L/min, Speed = 12.4 krpm. Steady 
Errors: H-H0  = 98 – 106 = - 8mmHg, CO – CO0 = 9.3 – 8.7 = 0.6L/min (see Figure 6.9).  
 




























Time (seconds)  
a. Forced changes to simulate exercise. 






























Time (seconds)  
 
b. K1=0.004, K2=0.004, LVPr=50 mmHg. 
Noise free (rest to exercise 2 at 15s) 
 
Figure 6.23. Simulation from rest to exercise 
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6.4.1 K1 and K2 
Theses two gains will determine the responsiveness the controller and the actual operating point 
relative to the estimated positions for H and CO branches.  Figure 6.24 and Figure 6.25 show the 
responsiveness of the controller with gains proportionally increased or decreased. The steady 
operating points are the same for both cases, but the transitions from rest to exercise are different 
due to different gain values. 
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Figure 6.24. K1=0.007, K2=0.007, LVPr=50 mmHg 
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Time (seconds)  
Figure 6.25. K1=0.002, K2=0.002, LVPr=50 mmHg 
 
The relative ratio of K1 to K2 will determine the position of the actual operating point in 
the H-Q plane. In Figure 6.26, the actual operating point is close to the operating point 
determined by the estimated reference value CO0 if K1 is smaller and K2 is larger. Similarly, in 
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Figure 6.27, the actual operating point is close to the operating point determined by the estimated 
reference value H0  if K1 is larger and K2 is smaller. 
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Time (seconds)  
 
Figure 6.26. K1< 0.004, K2>0.004, noise free (rest to exercise 2) 
K1=0.001, K2=0.01, LVPr=50 mmHg, 
Operating point: H = 92 mmHg, CO = 8.8 L/min, Speed = 12.0 krpm. 
The CO branch dominates.  
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Time (seconds)  
 
Figure 6.27. K1>0.004, K2<0.004. noise free (rest to exercise 2) 
K1=0.008, K2=0.001, LVPr=50 mmHg, 
Operating point: H = 104 mmHg, CO = 9.4 L/min, Speed = 12.7 krpm 
The H branch dominates. 
 
Tables 6.5, 6.6 list the steady state simulation results for different pairs of proportional 
K1 and K2. CO means the total flow in the tables (the aortic valve is closed). Figure 6.28 
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summarizes these simulation results. It can be concluded that keeping the relative ratio the same, 
the values for K1 and K2 affect the transient response from rest to exercise but not the steady 
states. The relative ratio of K1 to K2 will affect the actual operating point relative to the 
estimated operating points corresponding to H0 and CO0. 
 
Table 6.5. Simulation results with K1=0.005, K2=0.005 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9566 10,996 12,354 13,280 
MAP (mmHg) 87 104 125 140 
HR (bpm) 77 89 109 136 
CO (L/min) 5.2 7.5 9.1 10.5 
SVR (mmHg/ml/s) 0.85 0.75 0.73 0.71 
O1, O2 are offsets in outbound nervous signals in spikes/s 
R13: active muscle resistance 
=50 mmHg rLVP  
 
Table 6.6. Simulation results with K1=0.003, K2=0.003 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9569 11,009 12,317 13,216 
MAP (mmHg) 87 104 125 139 
HR (bpm) 77 89 109 136 
CO (L/min) 5.3 7.3 9.3 10.7 
SVR (mmHg/ml/s) 0.85 0.75 0.73 0.71 
=50 mmHg rLVP  
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Figure 6.28. Simulation results with different K1 and K2. 
Diamond: K1=0.005, K2=0.005; Square: K1=0.004, K2=0.004; Triangle: K1=0.003, K2=0.003. 
6.4.2 LVPr   
This preset parameter affects the estimated reference value H0. Specifically, the smaller LVPr 
implies larger H0 according to (6.6). In this way it will have effect on the estimated operating 
point for H branch and consequently the actual operating point. Figure 6.29 gives an example of 
a smaller LVPr with the other parameters kept the same. K1 = 0.004, K2 = 0.004, LVPr = 30 
mmHg. The smaller LVPr increases the difference between the estimated operating points for H 
branch and for CO branch. The resulting steady errors for both the H branch and CO branch are 
increased. 
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Time (seconds)  
 
Operating point: H = 108mmHg, CO = 9.7 L/min, Speed = 12.9 krpm 
Steady Errors: H-H0=108-126=-18mmHg, CO-CO0=9.7-8.7=1.0L/min 
Figure 6.29. LVPr <50 mmHg 
 
Tables 6.7 and 6.8 list the simulation results for the controller responses to multiple levels 
of exercise with different values of LVPr. Figure 6.30 summarizes these results. It can be seen 
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that there are some increases in blood pressure and pump flow with the decrease in LVPr but the 
changes are not significant. 
 
Table 6.7. Simulation results with LVPr = 40 mmHg 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9,723 11,228 12,613 13,517 
MAP (mmHg) 87 107 129 144 
HR (bpm) 76 89 109 136 
CO (L/min) 5.5 7.6 9.6 11.0 
SVR (mmHg/ml/s) 0.83 0.75 0.73 0.71 
 
 
Table 6.8. Simulation results with LVPr = 30 mmHg 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9,874 11,467 12,865 13,763 
MAP (mmHg) 88 110 132 147 
HR (bpm) 75 88 109 136 
CO (L/min) 5.8 8.0 9.7 11.1 
SVR (mmHg/ml/s) 0.81 0.75 0.73 0.71 
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Figure 6.30. Simulation results with different rLVP . K1=0.004, K2=0.004. 
Diamond: ; Square: ; Triangle: .  =50mmHgrLVP =40mmHgrLVP  =30mmHgrLVP
6.4.3 SVr   
The value of SVr has effect on both the H and CO branches according to (6.4), (6.5), and (6.6). 
A smaller SVr will result in less estimated reference H0 and CO0. Figure 6.31 gives an example 
for a smaller SVr with the other parameters kept the same. In this simulation, K1 = 0.004, K2 = 






≤⎧= ⎨ >⎩      (6.13) 
Table 6.9 lists the simulation results. The resultant operating speed is lower but the steady errors 






≤⎧= ⎨ >⎩      (6.14) 
the resultant operating speed is higher. The simulation results are listed in Table 6.10. Figure 
6.32 summarizes the simulation results with different SVr values. 
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Figure 6.31. Smaller SVr. 
Operating point: H = 90mmHg, CO = 8.7 L/min, Speed = 11.9 krpm 







Table 6.9. Simulation results with smaller SVr 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9,348 10,648 11,864 12,981 
MAP (mmHg) 86 101 119 136 
HR (bpm) 80 91 109 136 
CO (L/min) 5.2 7.1 8.7 10.4 
SVR (mmHg/ml/s) 0.88 0.76 0.73 0.71 
 
 
Table 6.10. Simulation results with larger SVr 
Exercise level  0 1 2 3 








Pump Speed (rpm) 9,775 11,356 12,688 13,549 
MAP (mmHg) 88 108 129 143 
HR (bpm) 76 88 109 136 
CO (L/min) 5.5 7.8 9.5 10.8 
SVR (mmHg/ml/s) 0.83 0.75 0.73 0.71 
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Figure 6.32. Simulation results with different SVr. 
 




















6.4.4 Noise  
For the application of the controllers, the measurement noise or uncertainty will present in the 
inputs of the controllers. Therefore it is necessary to test the robustness to the noise added to the 
controller inputs. Since the features of the hemodynamic variables measurement noise are not 
clear, two types of noises are simulated in this subsection: the uniformly distributed noise and the 
normally distributed noise. The noises are added to the HR, SVR, H, and CO in the diagram of 
Figure 6.7. 
 
1) Uniformly distributed noise 
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The noise feature is shown in Figure 6.33 and the responses of the controller to different levels 
and combinations of noise are shown in Figure 6.34 through 6.39.  
 














a. Measured H: 98 mmHg; Noise: [-10, 10] mmHg uniformly distributed 
 


















b. Measured CO: 154 ml/s; Noise: [-20, 20] ml/s uniformly distributed 
 
Figure 6.33. Noise features 
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Time (seconds)  
a. Response of the controller to exercise 
 
























Time (seconds)  
b. Measured operating point  
 
Figure 6.34. Low level of noises for HR, SVR, H and CO 
Operating point: H = 102 mmHg, CO = 9.1 L/min, Speed = 12.2 krpm 
SNR_CO: 23 dB, SNR_H: 26 dB, SNR_SVR: 26 dB, SNR_HR: 25 dB. 
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a. Response of the controller to exercise 
 
























Time (seconds)  
b. Measured operating point  
 
Figure 6.35. High level of noise for H only 
SNR_H: 14 dB (S/N: 98/[-40,40] in mmHg) 
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Time (seconds)  
a. Response of the controller to exercise 
 























Time (seconds)  
b. Measured operating point  
 
Figure 6.36. High level of noise for CO only 
SNR_CO: 11 dB (S/N: 154/[-80,80] in ml/s) 
 
 135 































Time (seconds)  
a. Response of the controller to exercise 
 
























Time (seconds)  
b. Measured operating point  
 
Figure 6.37. High level noise for SVR only 
SNR_SVR: 14 dB (S/N: 0.73/[-0.4,0.4] in mmHg/ml/s)  
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Time (seconds)  
a. Response of the controller to exercise 
 























Time (seconds)  
b. Measured operating point  
 
Figure 6.38. High level of noise for HR only 
SNR_HR: 14 dB (S/N: 1.8/[-0.8, 0.8] in 1/s) 
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Time (seconds)  
b. Measured operating point  
 
Figure 6.39. High level of noise for HR, SVR, H and CO 
SNR_CO: 15 dB, SNR_H: 17dB, SNR_SVR: 17 dB, SNR_HR: 17 dB 
 
The following is a summary of uniformly distributed noise effect (only one of them 
presents at a time): 
 138 
• SNR_H = 0 dB, works 
• SNR_CO = 0 dB, works 
• SNR_SVR = 0 dB, works 
• SNR_HR < 5 dB, does not work 
 
2) Normally distributed noise 
Similarly, different levels of normally distributed noises are added to the variables. The 
noise feature is shown in Figure 6.40 and the responses of the controller to different levels and 
combinations of noise are shown in Figure 6.41 through 6.44.  
 
 


















a. Noise feature for H  
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Figure 6.40. Noise for H only 
























a. Noise feature for CO 
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c. Measured operating point  
 
Figure 6.41. Noise for CO only 
SNR_CO: 12 dB (S: 154 ml/s, N:(0,40)) 
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Figure 6.42. Noise for SVR only 
SNR_H: -5 dB (S: 98 mmHg, N: (0,160) ) 
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Time (seconds)  
b. Measured operating point  
 
Figure 6.43. Noise for HR only 
SNR_HR: 12 dB (S: 1.8 1/s, N: (0, 0.4)) 
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Time (seconds)  
b. Measured operating point  
 
Figure 6.44. Noise for all variables 
SNR_CO: 12 dB, SNR_H: 13 dB, SNR_SVR: 12 dB, SNR_HR: 12 dB 
 
The following is a summary of normally distributed noise effect (only one of them 
presents at a time): 
• SNR_H = 0, works 
• SNR_CO = 0, works 
• SNR_SVR = 0, works 
• SNR_HR <10 dB, does not work 
6.5 CONCLUSION 
A controller based on the heart rate and systemic vascular resistance is developed and examined 
by comparing to other control methods such as constant speed, constant pump head and heart 
rate related pump speed methods in the literature. The proposed controller is implemented in the 
combined model of the pump and the failing cardiovascular system with built-in baroreflex. The 
proposed controller is responsive to change in physiological state. The proposed controller can 
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provide more blood flow than the constant speed and constant pump head methods and avoid the 
excessive mean arterial pressure generated by the heart rate related pump speed method. From 
rest to exercise, the controlled arterial pressure and cardiac output increase. The controller 
performance does not vary greatly due to changes in preset parameters LVPr, SVr, K1, and K2. 




7.0  CONCLUSION AND FUTURE WORK 
The development of a control algorithm for an LVAD supporting a patient with heart failure is a 
challenging engineering problem. In this dissertation, we investigated the control algorithm for 
improving the rotary pump performance for patients with heart failure. An LVAD controller 
based on the heart rate and the systemic vascular resistance is proposed. The investigations 
include improving the cardiovascular system model and the pump controller that will respond to 
the instantaneous physiological change of the body.  
In this dissertation, the baroreflex model is coupled to a cardiovascular system model and 
the interaction between the pump and the cardiovascular system with built-in baroreflex is 
simulated. The cardiovascular system model is a circuit analog model by using resistances, 
inductors, capacitors and diodes in which some parameter values can be varied by baroreflex. A 
healthy and a failing cardiovascular system models with built-in baroreflex have been developed 
by using the data in the literature as reference.  The pathophysiological changes in the failing 
cardiovascular system and the baroreflex have been mapped into the model and different types of 
clinical heart failure can be simulated by certain combinations of parameters such as dilated and 
hypertrophic heart failure. An empirical rotary pump model is coupled to the failing 
cardiovascular system model with built-in baroreflex. These models are capable of reproducing 
the real data in the literature, such as exercise experimental data for the healthy people and 
patients with heart failure. The combined model provides a realistic simulation of the interaction 
between the pump and the native cardiovascular system. The P-V loops and hemodynamic 
variable changes with increasing pump speed are consistent with clinical observations. More 
useful changes in hemodynamics can be simulated and exploited in this model for the LVAD 
control purpose, such as heart rate and systemic vascular resistance. This model can also be used 
to test the performance of a pump controller before the costly and time consuming animal 
experiments. 
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A physiological control algorithm was developed which incorporates the heart rate and 
the systemic vascular resistance as inputs. The changes in these hemodynamic variables are 
related to the baroreflex and local vessel dilation during exercise and are observed in exercise 
experiments. The changes in heart rate and the systemic vascular resistance are two important 
indicators of the exercise intensity. By including this information as control input, the controller 
relates the pump speed to these changes and can improve the pump support for the patients with 
changing physiological state. This algorithm is tested on the combined model of the pump and 
the native cardiovascular system with built-in baroreflex. The performance of this controller was 
compared to that of other pump control methods, such as the constant speed, constant pump head 
and heart rate related pump speed methods. For comparison, the parameters for the constant 
speed and constant pump head methods are chosen to match the hemodynamics at rest; the 
parameters for heart rate related pump speed method are chosen to match the hemodynamics at 
rest and exercise level 1. The simulation results show that the proposed controller: (1) is 
responsive to exercise intensity; and (2) can generate more pump flow than the constant speed 
and the constant pump head methods and the heart rate related pump speed method. The 
simulation results with noise also show that the controller is robust to noises imposed on the 
measured hemodynamic variables. The noises tested here are uniformly distributed and normally 
distributed since the noise characteristics are not clear for the hemodynamics measurement. 
There are some assumptions in the development of the controller, such as the 
measurability of blood pressure and blood flow, the closure of the aortic valve due to decreased 
left ventricular contractility. If these variables can not be measured in real life due to the 
difficulty or complexity, the estimations of them should be made by using pump current and/or 
pump voltage. As to the closure of the aortic valve, there are two possible scenarios: (1) we 
expect to have heart recovery by using partial support from the pump and (2) the heart muscle 
may recover the contractility after a period of full pump support and can open the aortic valve by 
itself. For both scenarios, we need to know the ratio of the pump flow to the aortic flow and 
adjust the values for the controller parameters SVr and LVPr.  
So far, the work has been done on the model simulation only. In the simulation, the heart 
rate and systemic vascular resistance are controlled by the baroreflex and are assumed to be 
available. In real life, there may be some complexity with the measurement of these variables. 
Especially, for the case of the heart rate, it is possible that there is an irregular cardiac rhythm or 
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missing beats. Thus preprocessing or measurement conditioning needs to be considered for the 
application of this controller. As to the selection of the pump speed update gains in the 
controller, some more complicated algorithm based on a certain objective may be considered to 
enhance the performance of the controller response to exercise. The future work includes further 
verification of this control method by using mock loop (with baroreflex) and animal experiment. 
Also, to avoid the adverse phenomenon such as suction, a suction detector should be 
incorporated into the controller as a safeguard. This control algorithm can also be incorporated as 
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